Profil

Chapelle Jean-Paul

Département de pharmacie

See author's contact details
Main Referenced Co-authors
Cavalier, Etienne  (123)
Delanaye, Pierre  (73)
Albert, Adelin  (71)
Heusghem, C. (64)
Kulbertus, Henri  (56)
Main Referenced Keywords
Humans (34); Female (26); Male (25); Middle Aged (21); Adult (17);
Main Referenced Unit & Research Centers
Giga-Signal Transduction - ULiège [BE] (8)
Giga Neurosciences - ULiège [BE] (2)
GIGA‐R - Giga‐Research - ULiège [BE] (1)
Giga-Signal Transduction, GIGA-R (1)
Main Referenced Disciplines
Laboratory medicine & medical technology (482)
Cardiovascular & respiratory systems (35)
Urology & nephrology (30)
Orthopedics, rehabilitation & sports medicine (18)
General & internal medicine (16)

Publications (total 556)

The most downloaded
42483 downloads
TEIXEIRA, J., Guillaume, M., NELLESSEN, E., & Chapelle, J.-P. (2012). BNP et NT-proBNP: valeurs de référence et seuils décisionnels. Revue Médicale de Liège, 67 (1), 38-43. https://hdl.handle.net/2268/114513

The most cited

400 citations (Scopus®)

Creppe, C., Malinouskaya, L., Volvert, M.-L., Gillard, M., Close, P., Malaise, O., Laguesse, S., Cornez, I., Rahmouni, S., Ormenese, S., Belachew, S., Malgrange, B., Chapelle, J.-P., Siebenlist, U., Moonen, G., Chariot, A., & Nguyen, L. (06 February 2009). Elongator controls the migration and differentiation of cortical neurons through acetylation of a tubulin. Cell, 136, 551-564. doi:10.1016/j.cell.2008.11.043 https://hdl.handle.net/2268/5901

LE GOFF, C., Kaux, J.-F., LAURENT, T., Vannuscorps, J., SEIDEL, L., Rodriguez de la Cruz, C., Forthomme, B., Bury, T., CHAPELLE, J.-P., Cavalier, E., & Croisier, J.-L. (September 2016). The cardiovascular impact of intense eccentric isokinetic exercise versus aerobic treadmill running. Isokinetics and Exercise Science, 24 (3), 201-208. doi:10.3233/IES-160618
Peer Reviewed verified by ORBi

LE GOFF, C., Kaux, J.-F., D'OTREPPE DE BOUVETTE, S., Goffaux, S., Fillet, M., Chapelle, J.-P., & Cavalier, E. (August 2016). Release of cardiac biomarkers during a cycling race. World Journal of Cardiovascular Diseases, 6 (8), 285-294.
Peer reviewed

Hoge, A., Donneau, A.-F., Streel, S., Kolh, P., CHAPELLE, J.-P., Albert, A., CAVALIER, E., & Guillaume, M. (December 2015). La déficience en vitamine D est fréquente chez les adultes wallons: résultats de l'étude "Nutrition, Environnement et Santé CardioVasculaire". Ortho-Rhumato, 13 (6), 31-36.
Peer reviewed

Hoge, A., Donneau, A.-F., Streel, S., Kolh, P., CHAPELLE, J.-P., Albert, A., CAVALIER, E., & Guillaume, M. (August 2015). Vitamin D deficiency is common among adults in Wallonia (Belgium, 51°30′ North): findings from the Nutrition, Environment and Cardio-Vascular Health study. Nutrition Research, 35 (8), 716-25. doi:10.1016/j.nutres.2015.06.005
Peer Reviewed verified by ORBi

DE SENY, D., COBRAIVILLE, G., CHARLIER, E., NEUVILLE, S., LUTTERI, L., LE GOFF, C., MALAISE, D., MALAISE, O., CHAPELLE, J.-P., RELIC, B., & MALAISE, M. (2015). Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory properties. PLoS ONE. doi:10.1371/journal.pone.0122904
Peer Reviewed verified by ORBi

Streel, S.* , Donneau, A.-F.* , Hoge, A., Majerus, S., KOLH, P., CHAPELLE, J.-P., Albert, A., & Guillaume, M. (2015). Socioeconomic impact on the prevalence of cardiovascular risk factors in Wallonia, Belgium: a population based-study. BioMed Research International, 1-10. doi:10.1155/2015/580849
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

LE GOFF, C., Kaux, J.-F., LAURENT, T., Vannuscorps, J., PINCEMAIL, J., Chapelle, J.-P., Cavalier, E., & Croisier, J.-L. (May 2014). Is isokinetic eccentric exercise dangerous for the heart? Isokinetics and Exercise Science, 22 (2), 131-136. doi:10.3233/IES-130529
Peer Reviewed verified by ORBi

LE GOFF, C., Kaux, J.-F., MELON, P., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (September 2013). Running races: study of the stress and cardiac biomarkers. European Journal of Sports Medicine, 1 (Supplement 1), 212.
Peer Reviewed verified by ORBi

LE GOFF, C., Kaux, J.-F., Leroy, L., PINCEMAIL, J., Chapelle, J.-P., & Cavalier, E. (September 2013). Fatty acids and associated cardiovascular risk. Food and Nutrition Sciences, 4 (9A), 188-194.
Peer reviewed

LE GOFF, C., MELON, P., Thébault, J., Kaux, J.-F., Cavalier, E., & Chapelle, J.-P. (2013). Impact of different endurance races on the heart: the point of view of the biologist. In Book of abstracts of 18th Annual Congress of the ECSS (pp. 93-94). ECSS.
Peer reviewed

LE GOFF, C., MELON, P., BREVERS, E., Fillet, M., Kaux, J.-F., Chapelle, J.-P., & Cavalier, E. (2013). Comparison of the Heart-type fatty acid-binding protein (H-FABP) with the high sensitive cardiac troponin T in healthy runners. In Book of abstracts of 18th Annual Congress of the ECSS (pp. 465).
Peer reviewed

GKIOUGKI, E., TEIXEIRA, J., SCHUMACHER, K., CHAPELLE, J.-P., & SEGHAYE, M.-C. (May 2013). Measurement of ultrasensitive Troponin T levels in cord blood for early detection of myocardial cell damage after birth [Paper presentation]. 47th Annual Meeting of the Association for European Paediatric and Congenital Cardiology, Londres, United Kingdom.

LE GOFF, C., Kaux, J.-F., MELON, P., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Race Cycling: biological evolution. Biochimica Clinica, 37 (SS), 544.
Peer reviewed

LE GOFF, C., MELON, P., Kaux, J.-F., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Impact of strenuous exercise on the release of cardiac biomarkers. Biochimica Clinica, 37 (SS), 545.
Peer reviewed

Dierge, L., LUTTERI, L., Chauvet, D., Hastir, D., CHAPELLE, J.-P., & CAVALIER, E. (May 2013). Heavy/light chain (HLC) and free light chain (FLC) analysis allow sensitive monitoring of multiple myeloma patients and AID detection of clonal changes. Biochimica Clinica, 37 (SS), 618.
Peer reviewed

LE GOFF, C., Kaux, J.-F., BREVERS, E., Fillet, M., MELON, P., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Comparison of the Heart-type fatty acid-binding protein (H-FABP) with the high sensitive cardiac troponin T in healthy runners. Biochimica Clinica, 37 (SS), 544.
Peer reviewed

PINCEMAIL, J., PAQUOT, N., Cillard, J., Hininger, I., Iuliano, L., Cazaubiel, M., Guéraud, F., CHAPELLE, J.-P., Kevers, C., CHARLIER, C., Albert, A., & DEFRAIGNE, J. (2013). On the Potential Effect of Increased Dietary Intake of Fruits and Vegetables on Biomarkers of Lipid Peroxidation in Type 2 Diabetes Patients. Journal of Pharmacy and Nutrition Sciences, 3 (3). doi:10.6000/1927-5951.2013.03.03.3
Peer reviewed

Fillet, M., Deroyer, C., COBRAIVILLE, G., LE GOFF, C., Cavalier, E., Chapelle, J.-P., Marée, R., Legrand, V., Pierard, L., Kolh, P., & Merville, M.-P. (2013). Identification of protein biomarkers associated with cardiac ischemia by a proteomic approach. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 18 (7), 614-24. doi:10.3109/1354750X.2013.838306
Peer Reviewed verified by ORBi

Rouatbi, H., GKIOUGKI, E., TEIXEIRA, J., CHAPELLE, J.-P., & SEGHAYE, M.-C. (2013). Measurement of ultrasensitive troponin T levels in cord blood for the early detection of myocardial cell damage after birth [Paper presentation]. Belgian Society of Cardiology - 32nd Annual Scientific Meeting, Bruxelles, Belgium.

LE GOFF, C., Kaux, J.-F., Leroy, L., Cavalier, E., & Chapelle, J.-P. (October 2012). Le dosage des acides gras érythrocytaires : comparaison entre une population de référence et des sujets ayant présenté un infarctus aigu du myocarde. Immuno-Analyse and Biologie Spécialisée, 27 (5), 237-243. doi:10.1016/j.immbio.2012.04.003
Peer reviewed

MALAISE, O., HALLEUX, S., VON FRENCKELL, C., LUTTERI, L., CHAPELLE, J.-P., & Malaise, M. (September 2012). Rhupus: when rheumatoid arthritis meets lupus. Revue Médicale de Liège, 67 (9), 475-84.
Peer reviewed

Close, P., Gillard, M., Ladang, A., Jiang, Z., Papuga, J., Hawkes, N., Nguyen, L., CHAPELLE, J.-P., Bouillenne, F., Svejstrup, J., Fillet, M., & Chariot, A. (2012). DERP6 (ELP5) and C3ORF75 (ELP6) regulate tumorigenicity and migration of melanoma cells as subunits of Elongator. Journal of Biological Chemistry. doi:10.1074/jbc.M112.402727
Peer Reviewed verified by ORBi

HAMDI, E., DELANAYE, P., LUTTERI, L., CHAPELLE, J.-P., & CAVALIER, E. (18 July 2012). analytical and Clinical Validation of Beta-Trace Protein, a New Marker of Glomerular Filtration Rate [Poster presentation]. AACC 2012, Los Angeles, United States.

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Analytical validation of the Perkin-Elmer MSMS Vit D for 25-Hydroxy-vitamin D determination on AB SCIEX TQ5500 [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., BEKAERT, A.-C., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Performance of the IDS-iSYS CROSSLAPS (CTX-I) Automated Immunoassay [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Evaluation of the Liaison 25-OH Vitamin D TOTAL Assay on the new DiaSorin Liaison XL [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (17 July 2012). Evaluation of Sclerostin levels in patients suffering from Chronic Kidney Diseases [Poster presentation]. AACC 2012, Los Angeles, United States.

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Evaluation of the Cross-reactivity of 25-Hydroxy-vitamin D2 on Six Commercial Immunoassays on Native Samples [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., MEURISSE, A., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Verification of the IDS-iSYS Intact Amino-terminal Propeptide of Type 1 Procollagen (P1NP) [Poster presentation]. AACC 2012, Los Angeles, United States.

LE GOFF, C., MELON, P., Kaux, J.-F., Fillet, M., & Chapelle, J.-P. (2012). Impact of strenous exercise on the release of cardiac biomarkers. In R. Meeusen, J. Duchateau, B. Roelands, M. Klass, B. De Geus, S. Baudry, ... E. Tsolakidis (Eds.), Book of Abstracts of the 17th annual Congress of the ECSS (pp. 36). ECSS.
Peer reviewed

LE GOFF, C., Kaux, J.-F., Goffaux, S., COUFFIGNAL, V., Coubard, R., LAURENT, T., MELON, P., Fillet, M., & Chapelle, J.-P. (2012). Race cycling: biological evolution. In R. Meeusen, J. Duchateau, B. Roelands, M. Klass, B. De Geus, S. Baudry, ... E. Tsolakidis (Eds.), Book of Abstracts of the 17th annual Congress of the ECSS (pp. 245). ECSS.
Peer reviewed

LE GOFF, C., Kaux, J.-F., Goffaux, S., MELON, P., Fillet, M., & Chapelle, J.-P. (2012). Biological variations during a race cycling. In Biomedica 2012 (pp. 157).
Peer reviewed

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., & Chapelle, J.-P. (18 February 2012). Human anti-animal interference in DiaSorin Liaison total 25(OH)-vitamin D assay: Towards the end of a strange story? Clinica Chimica Acta, 413 (3-4), 527-528. doi:10.1016/j.cca.2011.11.014
Peer Reviewed verified by ORBi

LE GOFF, C., LAURENT, T., GARWEG, C., Kaux, J.-F., HALENG, J., Charlier, C., & Chapelle, J.-P. (February 2012). Apport des troponines T et I ultrasensibles dans le diabète. Immuno-Analyse and Biologie Spécialisée, 27 (1), 40.
Peer reviewed

LE GOFF, C., Leroy, L., Kaux, J.-F., CAVALIER, E., & Chapelle, J.-P. (February 2012). Le dosage des acides gras érythrocytaires : comparaison entre une population de référence et des sujets ayant présenté un infarctus aigu du myocarde [Poster presentation]. 28e Colloque IBS CORATA, Namur, Belgium.

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (18 January 2012). New insights on the stability of the Parathyroid hormone as assayed by an automated 3rd generation PTH assay. Clinica Chimica Acta, 413 (1-2), 353-4. doi:10.1016/j.cca.2011.09.034
Peer Reviewed verified by ORBi

LE GOFF, C., LAURENT, T., Kaux, J.-F., & Chapelle, J.-P. (January 2012). Intense physical exercise related to the emergent generation of cardiovascular risk markers: a review. Biology of Sport, 29 (1), 11-16. doi:10.5604/20831862.979290
Peer Reviewed verified by ORBi

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., Chapelle, J.-P., & Souberbielle, J.-C. (2012). Analytical evaluation of the new Abbott Architect 25-OH vitamin D assay. Clinical Biochemistry, 45, 505-508. doi:10.1016/j.clinbiochem.2012.01.021
Peer Reviewed verified by ORBi

HAMDI, E., HALENG, J., LUTTERI, L., & CHAPELLE, J.-P. (2012). Influence of free kappa light chains in urine on total urinary protein: Results obtained by turbidimetry (MODULAR P800) and colorimetry (VITROS 350) [Poster presentation]. 29ème Colloque CORATA-BIOCLINORD, LILLE.

TEIXEIRA, J., Guillaume, M., NELLESSEN, E., & Chapelle, J.-P. (2012). BNP et NT-proBNP: valeurs de référence et seuils décisionnels. Revue Médicale de Liège, 67 (1), 38-43.
Peer reviewed

Jorgensen, B., Bertsch, T., Bröker, H.-J., Schäfer, M., Chapelle, J.-P., GADISSEUR, R., Cowie, M. R., Dikkeschei, B., Gurr, E., Hayen, W., Hafner, G., Stiegler, Y., Schönherr, H.-R., Strasser, R., Weidtmann, B., Folkerts, H., Zugck, C., Hofmann, K., & Zerback, R. (2012). Multicentre Evaluation of a Second Generation Point-of-Care Assay with an Extended Range for the Determination of N-Terminal Pro-Brain Natriuretic Peptide. Clinical Laboratory, 58, 515-525.
Peer Reviewed verified by ORBi

LAYIOS, N., LAMBERMONT, B., CANIVET, J.-L., MORIMONT, P., PREISER, J.-C., GARWEG, C., LEDOUX, D., FRIPPIAT, F., PIRET, S., GIOT, J.-B., WIESEN, P., MEURIS, C., MASSION, P., LEONARD, P., NYS, M., LANCELLOTTI, P., CHAPELLE, J.-P., & DAMAS, P. (2012). Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Critical Care Medicine, 40 (8), 2304-9. doi:10.1097/CCM.0b013e318251517a
Peer Reviewed verified by ORBi

FAILLA, V., CAVALIER, E., EL HAYDERI, L., PAUROBALLY, D., Chapelle, J.-P., DEZFOULIAN, B., & NIKKELS, A. (2012). Seasonal variations in vitamin D levels in melanoma patients: a single-centre prospective pilot comparative study. Journal of the European Academy of Dermatology and Venereology, 26 (5), 651-3. doi:10.1111/j.1468-3083.2011.04087.x
Peer Reviewed verified by ORBi

CAVALIER, E., DELANAYE, P., VRANKEN, L., BEKAERT, A.-C., CARLISI, I., Chapelle, J.-P., & SOUBERBIELLE, J.-C. (2012). Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values. Nephrology Dialysis Transplantation, 27, 1950-56. doi:10.1093/ndt/gfr535
Peer Reviewed verified by ORBi

RADERMECKER, R., CHAPELLE, J.-P., PAQUOT, N., & Thielen, V. (December 2011). Undetectable HbA1c in a type 2 diabetic woman: Case report of a rare haemoglobin variant [Poster presentation]. International diabetes federation IDF 2011, World Diabetes Congress, Dubai, United Arab Emirates.

TEIXEIRA, J., WOTQUENNE, P., D'ORIO, V., Gruson, D., & Chapelle, J.-P. (15 October 2011). Early assessment of myocardial injury by joint measurement of TnT-hs and Copeptin [Poster presentation]. BVKB-SBBC Annual Meeting - The Future of Clinical Biology, Liège, Belgium.

DE BACKER, B., Poncin, J., HALENG, J., CHAPELLE, J.-P., & CAVALIER, E. (15 October 2011). Comparison between the new AccuChek Inform II glucose meter and the Rapidlab 865 blood gas analyzer: implications for use of the Inform II in tight glycemic control [Poster presentation]. BVKB - SBBC (Belgian Society for Clinical Biology) Annual Symposium 2011, Liège, Belgium.

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., Chapelle, J.-P., & DELANAYE, P. (October 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay. Clinical Chemistry, 57 (S10), 190.
Peer Reviewed verified by ORBi

CAVALIER, E., PONCIN, J., MUSSO, G., HALENG, J., & Chapelle, J.-P. (October 2011). Analytical validation of Accu-check Inform II meters and strips before their use in the wards: pratical experience of the CHU de Liège. Clinical Chemistry, 27 (S10), 143.
Peer Reviewed verified by ORBi

CAVALIER, E., DELANAYE, P., VRANKEN, L., CARLISI, I., BEKAERT, A.-C., Chapelle, J.-P., & Souberbielle, J.-C. (October 2011). Impact of the use of the Manufacture's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines. Clinical Chemistry, 57 (S10), 191.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (29 September 2011). High sensitive troponin: pratical guidelines [Paper presentation]. Turning science into caring, Vilvorde, Belgium.

CAVALIER, E., BEKAERT, A.-C., CARLISI, I., & CHAPELLE, J.-P. (17 September 2011). Automated Measurement of Total 25OH Vitamin D in the IDS iSYS System [Poster presentation]. ASBMR 2011 Annual Meeting, San-Diego, United States.

LE GOFF, C., Kaux, J.-F., GARWEG, C., LAURENT, T., Vannuscorp, J., Rodriguez de la Cruz, C., Bury, T., & Chapelle, J.-P. (2011). La troponine T ultrasensible : un nouvel outil diagnostic pour le médecin sportif? In 4ème Congrès commun SFMS & SFTS (pp. 87-88).
Peer reviewed

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (28 July 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay [Poster presentation]. AACC, Atlanta, United States.

CAVALIER, E., DELANAYE, P., Vranken, L., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & Souberbielle, J.-C. (28 July 2011). Impact of the use of the Manufacturer's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines [Poster presentation]. AACC, Atlanta, United States.

CAVALIER, E., PONCIN, J., MUSSO, G., HALENG, J., & CHAPELLE, J.-P. (27 July 2011). Analytical validation of Accu-check Inform II meters and strips before their use in the wards: practical experience of the CHU de Liège [Poster presentation]. AACC 2011, Atlanta, United States.

LE GOFF, C., Leroy, L., Kaux, J.-F., CAVALIER, E., & Chapelle, J.-P. (May 2011). Fatty acids and cardiovascular risk. Clinical Chemistry and Laboratory Medicine, 49 (Special Suppl), 313.
Peer Reviewed verified by ORBi

LE GOFF, C., Bury, T., Rodriguez de la Cruz, C., Kaux, J.-F., Vannuscorps, J., Chapelle, J.-P., & Croisier, J.-L. (May 2011). Elevation of cardiac and oxidative stress biomarkers after a running activity in sedentary subjects. Clinical Chemistry and Laboratory Medicine, 49 (Special Suppl), 313.
Peer Reviewed verified by ORBi

LE GOFF, C., GARWEG, C., Kaux, J.-F., MELON, P., LANCELLOTTI, P., Pierard, L., & Chapelle, J.-P. (May 2011). Use of a novel high-sensitivity troponin T, I and MPO, NT-proBNP assays to detect myocardial injury in patients with atrial fibrillation treated by direct-current cardioversion. Clinical Chemistry and Laboratory Medicine, 49 (Special Suppl), 312.
Peer Reviewed verified by ORBi

LE GOFF, C., Leroy, L., Pincemail, J., Kaux, J.-F., CAVALIER, E., & Chapelle, J.-P. (2011). Fatty acids determinations: an cardiovascular risk? Preliminary results. In Biomedica - Life Science Summit (pp. 153).
Peer reviewed

Cavalier, E., Huberty, V., Carlisi, I., Chapelle, J.-P., Vroonen, L., & Beckers, A. (18 March 2011). Human anti-animal antibodies interference in the Siemens Immulite chemiluminescent insulin immuno-assay: about one case. Clinica Chimica Acta, 412 (7-8), 668-669. doi:10.1016/j.cca.2010.12.035
Peer Reviewed verified by ORBi

PAQUOT, N., PINCEMAIL, J., cillard, J., Hininger, I., Luliano, L., Cazaubiel, M., Guerard, F., CHAPELLE, J.-P., CHARLIER, C., & DEFRAIGNE, J. (March 2011). Effets d’un apport accru en fruits et légumes sur 9 marqueurs de la peroxydation lipidique chez des sujets diabétiques de type 2. Diabète et Métabolisme, 37, 38.
Peer Reviewed verified by ORBi

PINCEMAIL, J., Vanbelle, S., Degrune, F., CHERAMY-BIEN, J.-P., CHARLIER, C., Chapelle, J.-P., Giet, D., Collette, G., Albert, A., & Defraigne, J.-O. (2011). Lifestyle Behaviours and Plasma Vitamin C and β-Carotene Levels from ELAN Population (Liège, Belgium). Journal of Nutrition and Metabolism, 2011. doi:10.1155/2011/494370
Peer Reviewed verified by ORBi

CAVALIER, E., WALLACE, A. M., CARLISI, I., CHAPELLE, J.-P., DELANAYE, P., & SOUBERBIELLE, J.-C. (2011). Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples. Clinical Chemistry and Laboratory Medicine, 49 (3), 555-8. doi:10.1515/CCLM.2011.072
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Chapelle, J.-P., & Delanaye, P. (2011). Analytical validation of the Liaison Calcitonin_II-Gen (DiaSorin). Clinical Chemistry and Laboratory Medicine, 49 (2), 271-275. doi:10.1515/CCLM.2011.036
Peer Reviewed verified by ORBi

PAQUOT, N., PINCEMAIL, J., Cillard, J., Hininger, I., Luliano, L., Cauzaubiel, M., Guerard, F., CHAPELLE, J.-P., CHARLIER, C., & Defraigne, J.-O. (2011). Effets d’un accroissement en fruits et légumes sur neuf marqueurs de la peroxydation lipidique chez des sujets diabétiques de type 2. Diabète et Métabolisme, 37 (suppl 1), 38.
Peer Reviewed verified by ORBi

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (2011). A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP (c) 250 with the ImmunoCAP (c) ISAC. Clinical Chemistry and Laboratory Medicine, 49 (2), 277-80. doi:10.1515/CCLM.2011.052
Peer Reviewed verified by ORBi

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & SOUBERBIELLE, J.-C. (2011). Validation of the Abbott Architect 25(OH)-vitamin D assay. Clinical Chemistry and Laboratory Medicine, 49 (s1), 418.
Peer Reviewed verified by ORBi

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (18 November 2010). Analyse morphoconstitutionnelle des lithiases [Paper presentation]. GLEM de Biologie Clinique, Fléron, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (October 2010). New technologies in allergology, Workshop [Paper presentation]. Symposium BVKB/SBBC, Anvers, Belgium.

Vandevijvere, S., De Keyzer, W., Chapelle, J.-P., Jeanne, D., Mouillet, G., Huybrechts, I., Hulshof, P., & Van Oyen, H. (2010). Estimate of total salt intake in two regions of Belgium through analysis of sodium in 24h urine samples. European Journal of Clinical Nutrition. doi:10.1038/ejcn.2010.148
Peer Reviewed verified by ORBi

Cavalier, E., Daly, A., Betea, D., Pruteanu-Apetrii, P. N., Delanaye, P., Stubbs, P., Bradwell, A. R., Chapelle, J.-P., & Beckers, A. (August 2010). The Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 95, 3745-9. doi:10.1210/jc.2009-2791
Peer Reviewed verified by ORBi

Keutgens, A., Shostak, K., Close, P., Zhang-Shao, X., Hennuy, B., Aussems, M., Chapelle, J.-P., Viatour, P., Gothot, A., Fillet, M., & Chariot, A. (August 2010). The repressing function of the oncoprotein BCL-3 requires CtBP while its polyubiquitination and degradation involve the E3 ligase TBLR1. Molecular and Cellular Biology, 30, 4006-4021. doi:10.1128/MCB.01600-09
Peer Reviewed verified by ORBi

Le Goff, C., Garweg, C., Laurent, T., Kaux, J.-F., Deroyer, C., Merville, M.-P., Melon, P., Fillet, M., Legrand, V., & Chapelle, J.-P. (July 2010). Assessment of high sensitive troponin T and I immunoassays in patients with acute chest. Clinical Chemistry, 56 (S6), 127.
Peer Reviewed verified by ORBi

Le Goff, C., Laurent, T., Garweg, C., Kaux, J.-F., Deroyer, C., Fillet, M., Lancellotti, P., Pierard, L., & Chapelle, J.-P. (July 2010). Does echocardiographic stress test induced release of hsTnT and TnI II? Clinical Chemistry, 56 (S6), 128.
Peer Reviewed verified by ORBi

Cavalier, E., Saarbach, D., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Analytical validation of the Abbott Architect urine NGAL. Clinical Chemistry, 56 (S6), 96.
Peer Reviewed verified by ORBi

Cavalier, E., Rousselle, O., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Evaluation of the DiaSorin Liaison 1-84 PTH Assay, a new automated immunoassay for the determination of the 3rd Generation PTH. Clinical Chemistry, 56 (S6), 56.
Peer Reviewed verified by ORBi

Cavalier, E., Daly, A., Betea, D., Pruteanu Apetrii, P., Delanaye, P., Stubbs, P., Bradwell, A. R., Chapelle, J.-P., & Beckers, A. (June 2010). The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma. Clinical Chemistry, 56 (S6), 188.
Peer Reviewed verified by ORBi

Gadisseur, R., Blanco Catafal, A., Chapelle, J.-P., & Cavalier, E. (June 2010). Validation of the ImmunoCAP ISAC. Clinical Chemistry, 56 (S6), 97.
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Delanaye, P., & Chapelle, J.-P. (June 2010). Evaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination. Clinical Chemistry, 56 (S6), 188.
Peer Reviewed verified by ORBi

Close, P., Creppe, C., Gillard, M., LADANG, A., Chapelle, J.-P., Nguyen, L., & Chariot, A. (April 2010). The emerging role of lysine acetylation of non-nuclear proteins. Cellular and Molecular Life Sciences, 67 (8), 1255-1264. doi:10.1007/s00018-009-0252-7
Peer Reviewed verified by ORBi

Le Goff, C., Laurent, T., Chapelle, J.-P., & Kaux, J.-F. (20 March 2010). Release of cardiac biomarkers after an intense physical exercise: preliminary results [Poster presentation]. VVS Biennial Congress for Sports Medicine and Sports Sciences, Brugge, Belgium.

Le Goff, C., Kaux, J.-F., Bovy, C., Da Silva, A., & Chapelle, J.-P. (March 2010). Comparaison des taux de BNP et de NT-proBNP chez des patients insuffisants rénaux pour prévenir l'insuffisance cardiaque. Biotribune Magazine, 34, 6-9. doi:10.1007/s11834-010-0004-x
Peer reviewed

Lutteri, L., Sagot, L., & Chapelle, J.-P. (March 2010). Anticorps anti-gliadines déamidées et maladie coeliaque : données actuelles et évaluation des faux positifs de cinq trousses de dosage. Annales de Biologie Clinique, 68 (2), 149-56. doi:10.1684/abc.2010.0398
Peer Reviewed verified by ORBi

Cavalier, E., Rozet, E., Gadisseur, R., Carlisi, I., Monge, M., Chapelle, J.-P., Hubert, P., Souberbielle, J.-C., & Delanaye, P. (2010). Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporosis International, 21, 1047-1051. doi:10.1007/s00198-009-1052-5
Peer Reviewed verified by ORBi

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (2010). Component-resolved-diagnosis and validation of an allergen-microarray technology. Allergy, 65 (suppl. 92), 93.
Peer Reviewed verified by ORBi

Cavalier, E., Daly, A., Chapelle, J.-P., Betea, D., Bradwell, A., Stubbs, P., Delanaye, P., & Beckers, A. (2010). The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma. In 12th European Congress of Endocrinology - ICE 2010.
Peer reviewed

Gadisseur, R., Chapelle, J.-P., Cavalier, E., & Blanco-Catafal Anna, U. O. B. (Other coll.). (2010). Component-resolved diagnosis in peanut and hazelnut allergy. Allergy, 65 (Suppl.92), 106.
Peer Reviewed verified by ORBi

Keutgens, A., Zhang-Shao, X., Shostak, K., Robert, I., Olivier, S., Vanderplasschen, A., Chapelle, J.-P., Viatour, P., Merville, M.-P., Bex, F., Gothot, A., & Chariot, A. (2010). BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1. Journal of Biological Chemistry, 285 (33), 25831–25840. doi:10.1074/jbc.M110.112128
Peer Reviewed verified by ORBi

De Bock, M., De Seny, D., Meuwis, M.-A., Servais, A.-C., Minh, T. Q., Closset, J., Chapelle, J.-P., Louis, E., Malaise, M., Merville, M.-P., & Fillet, M. (2010). Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis. Talanta, 82, 245-254. doi:10.1016/j.talanta.2010.04.029
Peer Reviewed verified by ORBi

Chapelle, J.-P., Teixeira, J., Maisin, D., Assink, H., Barla, G., Stroobants, A. K., Delzenne, B., & van den Eshof, W. (2010). Multicentre evaluation of the Tosoh HbA1c G8 analyser. Clinical Chemistry and Laboratory Medicine, 48 (3), 365-371. doi:10.1515/CCLM.2010.062
Peer Reviewed verified by ORBi

Ho, T. T. G., Keutgens, A., Chapelle, J.-P., & Cavalier, E. (2010). Corrélation aldostérone et parathormone en cas d'hyperparathyroïdie primaire vs secondaire? Annales de Biologie Clinique, 68 (6), 703-4.
Peer Reviewed verified by ORBi

Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Hubert, P., Chapelle, J.-P., & Delanaye, P. (January 2010). Analytical validation of the BAP OSTASE on Liaison (DiaSorin). Clinical Chemistry and Laboratory Medicine, 48 (1), 67-72. doi:10.1515/CCLM.2010.019
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Hubert, P., Krzesinski, J.-M., Chapelle, J.-P., & Rozet, E. (December 2009). Estimation of the Stability of Parathyroid Hormone when Stored at -80°C for a Long Period. Clinical Journal of the American Society of Nephrology, 4 (12), 1988-92. doi:10.2215/CJN.03970609
Peer Reviewed verified by ORBi

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (19 November 2009). CRD and technical validation of ImmunoCAPISAC [Paper presentation]. ImmunoCAP ISAC : First International Users Meeting, Diegem, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (19 November 2009). IMMUNOCAP© ISAC: INTEREST IN ALLERGY DIAGNOSIS [Poster presentation]. Symposium BVKB/SBBC, Mont-Godinne, Belgium.

Le Goff, C., Kaux, J.-F., Denooz, A., & Chapelle, J.-P. (03 November 2009). Cholestérol total, HDL, LDL et LDL oxydées : implications cardiovasculaires [Poster presentation]. 54ème Edition des Journées Internationales de Biologie, Paris, France.

Le Goff, C., Kaux, J.-F., Denooz, A., & Chapelle, J.-P. (03 November 2009). Myéloperoxydase, LDL oxydées et anticorps anti-LDL oxydées sont-ils interdépendants ? [Poster presentation]. 54ème Edition des Journées Internationales de Biologie, Paris, France.

Teixeira, J., Denooz, A., & Chapelle, J.-P. (November 2009). Measurement of HBA1c using the new vitros 5600 integrated system [Poster presentation]. Journées Internationales de Biologie.

Teixeira, J., Le Goff, C., Aldenhoff, M.-C., Bovy, C., Dubois, B., Krzesinski, J.-M., & Chapelle, J.-P. (October 2009). Comparison of myocardial makers for assessing cardiovascular and all cause 3-year mortality in dialysis patients [Poster presentation]. 20th international Congress of Clinical Chemistry and Laboratory Medicine, 35th Brazilian Congress of Clinical Analysis and 8th Brazilian Congress of Clinical Cytology, Fortaleza, Brazil.

Teixeira, J., Denooz, A., & Chapelle, J.-P. (July 2009). Evaluation of the VITROS 5600 integrated system for IgA IgG and IgM determination in serum. Clinical Chemistry, 55, 205.
Peer Reviewed verified by ORBi

Gach, O., Louis, O., Chapelle, J.-P., Vanbelle, S., Pierard, L., & Legrand, V. (July 2009). Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention. Heart and Vessels, 24 (4), 267-70. doi:10.1007/s00380-008-1120-3
Peer Reviewed verified by ORBi

Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Chapelle, J.-P., & Delanaye, P. (June 2009). ANALYTICAL PERFORMANCE OF THE C-TERMINAL FGF-23 (IMMUTOPICS). Clinical Chemistry and Laboratory Medicine, 47 (M-A032).
Peer Reviewed verified by ORBi

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (June 2009). A new diagnostic tool for in vitro allergy. Allergy, 64, 30-31.
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, I., Chapelle, J.-P., & Rozet, E. (June 2009). VALIDATION AND ACCURACY PROFILES OF THE LIAISON BAP_OSTASE (DIASORIN), A NEW METHOD FOR THE DETERMINATION OF BONE ALKALINE PHOSPHATASE. Clinical Chemistry and Laboratory Medicine, 47 (51).
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Bekaert, A.-C., Carlisi, I., & Chapelle, J.-P. (June 2009). Establishment of a reference range for the Bone Alkaline Phosphatase (BAP) with Diasorin Liaison in a biologically well-designed population. Clinical Chemistry, 55 (S6), 178.
Peer Reviewed verified by ORBi

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (29 May 2009). Nouveaux outils de diagnostic in-vitro des allergies [Paper presentation]. Symposium CPALF, Mont-Godinne, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (28 April 2009). ImmunoCAP© ISAC: interest in allergy diagnosis [Paper presentation]. Conférence du Cercle des jeunes chercheurs du CIRM, Liège, Belgium.

Robert, I., Aussems, M., Keutgens, A., Zhang-Shao, X., Hennuy, B., Viatour, P., Vanstraelen, G., Merville, M.-P., Chapelle, J.-P., de Leval, L., LAMBERT, F., Dejardin, E., Gothot, A., & Chariot, A. (02 April 2009). Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-κB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. Oncogene, 28 (13), 1626-1638. doi:10.1038/onc.2009.6
Peer Reviewed verified by ORBi

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (24 March 2009). Intérêt des allergènes recombinants: aspects biologiques [Paper presentation]. Jeudis de Fleurus, Haute Ecole Louvain en Hainaut, Fleurus, Belgium.

Creppe, C., Malinouskaya, L., Volvert, M.-L., Gillard, M., Close, P., Malaise, O., Laguesse, S., Cornez, I., Rahmouni, S., Ormenese, S., Belachew, S., Malgrange, B., Chapelle, J.-P., Siebenlist, U., Moonen, G., Chariot, A., & Nguyen, L. (06 February 2009). Elongator controls the migration and differentiation of cortical neurons through acetylation of a tubulin. Cell, 136, 551-564. doi:10.1016/j.cell.2008.11.043
Peer Reviewed verified by ORBi

LAYIOS, N., LAMBERMONT, B., LEDOUX, D., MORIMONT, P., MASSION, P., GARWEG, C., FRIPPIAT, F., NYS, M., CHAPELLE, J.-P., & DAMAS, P. (2009). Usefulness of procalcitonin for the decision of antibiotic treatment in ICU patients. Intensive Care Medicine, 35 (Suppl 1), 82.
Peer Reviewed verified by ORBi

Mistretta, V., Cavalier, E., Collette, J., & Chapelle, J.-P. (2009). Production des anticorps monoclonaux. Revue Médicale de Liège, 64 (5-6), 248-252.
Peer reviewed

Cavalier, E., Carlisi, I., Chapelle, J.-P., Orfanos, P., Uzan, M., Falque, V., Delanaye, P., & Hachicha, M. (2009). Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment. Transplantation, 87 (3), 451-2. doi:10.1097/TP.0b013e31819575a1
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., Scheen, A., & Krzesinski, J.-M. (2009). Estimation of GFR by different creatinine- and cystatin-C-based equations in anorexia nervosa. Clinical Nephrology, 71 (5), 482-91. doi:10.5414/CNP71482
Peer Reviewed verified by ORBi

Gillery, P., Périer, C., Bordas-Fonfrède, M., Hue, G., Chapelle, J.-P., Vexiau, P., & Vialettes, B. (2009). Propositions pour l'expression standardisée des résultats d'HbA1c. Annales de Biologie Clinique, 67 (6), 669-71. doi:10.1684/abc.2009.0391
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Chapelle, J.-P., & Souberbielle, J.-C. (2009). Vitamin D: current status and perspectives. Clinical Chemistry and Laboratory Medicine, 47 (2), 120-127. doi:10.1515/CCLM.2009.036
Peer Reviewed verified by ORBi

Gadisseur, R., Cataldo, D., Collard, L., Chapelle, J.-P., & Cavalier, E. (2009). Allergie au venin d'hyménoptère et tests de laboratoires : de nouvelles approches pour la prise en charge des patients à haut risque de réaction sévère. Revue Médicale de Liège, 64 (11), 570-5.
Peer reviewed

Pincemail, J., Le Goff, C., Charlier, C., Gillion, P., Cheramy-Bien, J.-P., Van Honacker, E., Chapelle, J.-P., & Defraigne, J.-O. (2009). Evaluation biologique du stress oxydant : application en routine clinique. Nutritions et Endocrinologie, Déc, 16-31.
Peer reviewed

Teixeira, J., Denooz, A., Haleng, J., Cavalier, E., & Chapelle, J.-P. (2009). Evaluation of the Vitros 5600 Integrated System for Enzymatic determination of Creatinine in blood plasma.

Le Goff, C., Haleng, J., & Chapelle, J.-P. (2009). Comparison of two immunoassays for quantitative measurement of oxydized-LDL. Immuno-Analyse and Biologie Spécialisée, 24, 183.
Peer reviewed

Mistretta, V., Cavalier, E., Collette, J., Lutteri, L., & Chapelle, J.-P. (2009). Intérêt des anticorps monoclonaux dans le laboratoire d'analyses biomédicales. Revue Médicale de Liège, 64 (5-6), 257-263.
Peer reviewed

De Bock, M., De Seny, D., Meuwis, M.-A., Chapelle, J.-P., Louis, E., Malaise, M., Merville, M.-P., & Fillet, M. (2009). Challenges for Biomarker Discovery in Body Fluids Using SELDI-TOF-MS. Journal of Biomedicine and Biotechnology. doi:10.1155/2010/906082
Peer Reviewed verified by ORBi

Le Goff, C., Bovy, C., Da Silva, A., Krzesinski, J.-M., & Chapelle, J.-P. (2009). Comparison of BNP and NT-proBNP performances for assessing heart failure in a population of patients with high incidence of with renal insufficiency. Annales de Biologie Clinique, 67 (1).
Peer Reviewed verified by ORBi

Le Goff, C., Haleng, J., Denooz, A., & Chapelle, J.-P. (2009). Comparison of two immunoassays for oxidized LDL determination. Annales de Biologie Clinique, 67 (1).
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., Chapelle, J.-P., & Collette, J. (2009). An unusual interference in parathormone assay caused by anti-goat IgG: a case report. Clinical Chemistry and Laboratory Medicine, 47 (1), 118. doi:10.1515/CCLM.2009.015
Peer Reviewed verified by ORBi

Renert, A.-F., Leprince, P., Dieu, M., Renaut, J., Raes, M., Bours, V., Chapelle, J.-P., Piette, J., Merville, M.-P., & Fillet, M. (2009). The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells. Journal of Proteome Research, 8 (10), 4810-22. doi:10.1021/pr9005316
Peer Reviewed verified by ORBi

Cavalier, E., Péroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (November 2008). Etude analytique des trois trousses de cystatine C et impact sur les formules basées sur la cystatine pour l'estimation du DFG. Néphrologie et Thérapeutique, 4 (6), 399-400.
Peer Reviewed verified by ORBi

Cavalier, E., Wallace, A. M., Knox, S., Mistretta, V., Chapelle, J.-P., & Souberbielle, J.-C. (September 2008). Circulating Concentrations of 25-Hydroxyvitamin D after a Single Oral Dose of 100.000 IU of Vitamin D2 or Vitamin D3. Journal of Bone and Mineral Research, 23, 212.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., & Chapelle, J.-P. (September 2008). Analytical Validation of Diasorin Liaison and Roche Elecsys Methods for the Determination of Osteocalcin. Journal of Bone and Mineral Research, 23, 191.
Peer Reviewed verified by ORBi

Cornez, I., Creppe, C., Gillard, M., Hennuy, B., Chapelle, J.-P., Dejardin, E., Merville, M.-P., Close, P., & Chariot, A. (June 2008). Deregulated expression of pro-survival and pro-apoptotic p53-dependent genes upon Elongator deficiency in colon cancer cells. Biochemical Pharmacology, 75, 2122-2134. doi:10.1016/j.bcp.2008.03.006
Peer Reviewed verified by ORBi

Chapelle, J.-P. (08 May 2008). Intérêt clinique du dosage ultrasensible de la procalcitonine [Paper presentation]. BioMérieux Workshop, Sart Tilman, Liège, Belgium.

Lutteri, L., Le Goff, C., & Chapelle, J.-P. (May 2008). Very high performance of deamidated gliadin peptide antibodies in the diagnosis of coeliac disease [Poster presentation]. International Symposium "Brussels 2008" SBCC, Bruxellles, Belgium.

Gilmaire, J., Descy, J., Haleng, J., Chapelle, J.-P., & Cavalier, E. (May 2008). Critical difference: from results to interpretation and its impact on patient care [Poster presentation]. International Symposium "Brussels 2008" Société Belge de Chimie clinique, brussels, Belgium.

Teixeira, J., Aldenhoff, M.-C., Bovy, C., Dubois, B., Krzesinski, J.-M., & Chapelle, J.-P. (May 2008). Low creatine kinase MM (CK-MM) levels are strongly associated with adverse outcome in haemodialysis patients [Poster presentation]. International Symposium of Laboratory Medicine - Brussels 2008, Bruxelles, Belgium.

Hody, S., Croisier, J.-L., Wang, F.-C., Chapelle, J.-P., Rogister, B., & Leprince, P. (2008). Interest of a comparative proteomic approach to unravel the aetiology of DOMS in humans. Acta Physiologica Scandinavica. Supplementum, 194 (suppl 666), 09.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Morreale, A., Carlisi, I., Mourad, I., Chapelle, J.-P., & Emonts, P. (2008). La carence en vitamine d chez les femmes enceintes en region liegeoise: un probleme meconnu. Revue Médicale de Liège, 63 (2), 87-91.
Peer reviewed

Gadisseur, R., Collard, L., Cataldo, D., Chapelle, J.-P., & Cavalier, E. (2008). Can laboratory tests help to define the profile of desensitised patients or patients at high risk of severe reaction ? Allergy, 63 (Suppl. 88), 1773.
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., Scheen, A., & Krzesinski, J.-M. (2008). Cystatin C or Creatinine for Detection of Stage 3 Chronic Kidney Disease in Anorexia Nervosa. Nephron. Clinical Practice, 110 (3), 158-c163. doi:10.1159/000166607
Peer Reviewed verified by ORBi

De Seny, D., Fillet, M., Ribbens, C., Marée, R., Meuwis, M.-A., Lutteri, L., Chapelle, J.-P., Wehenkel, L., Louis, E., Merville, M.-P., & Malaise, M. (2008). Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clinical Chemistry, 54, 1066-1075. doi:10.1373/clinchem.2007.099549
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., Chapelle, J.-P., & Krzesinski, J.-M. (2008). Prévalence de la maladie rénale chronique par l’estimation du DFG avec une formule basée sur la créatinine versus la cystatine C [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Delanaye, P., Pieroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., Hainque, B., & Cavalier, E. (2008). Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Clinica Chimica Acta, 398 (1-2), 118-24. doi:10.1016/j.cca.2008.09.001
Peer Reviewed verified by ORBi

Monfort, M., Delanaye, P., Chapelle, J.-P., & Cavalier, E. (2008). Calcium chez les patients hemodialyses : calcemie totale ou calcium ionise ? Le laboratoire doit-il systematiquement fournir au clinicien une valeur de calcemie totale corrigee obtenue par calcul ? Annales de Biologie Clinique, 66 (5), 573-6. doi:10.1684/abc.2008.0264
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (2008). Analytical quality of calcitonin determination and its effect on the adequacy of screening for medullary carcinoma of the thyroid [letter to the editor]. Clinical Chemistry, 54 (5), 929-30. doi:10.1373/clinchem.2007.100636
Peer Reviewed verified by ORBi

Gillery, Bordas-fonfrède, Chapelle, J.-P., Hue, & Perrier. (2008). Encore un pas vers la standardisation internationale du dosage d'HbA1c. Annales de Biologie Clinique, 66 (1), 6-8. doi:10.1684/abc.2008.0186
Peer Reviewed verified by ORBi

Meuwis, M.-A.* , Fillet, M.* , Lutteri, L., Marée, R., Geurts, P., De Seny, D., Malaise, M., Chapelle, J.-P., Wehenkel, L., Belaiche, J., Merville, M.-P., & Louis, E. (2008). Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study. Clinical Biochemistry, 41 (12), 960-7. doi:10.1016/j.clinbiochem.2008.04.021
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Le Goff, C., Kaux, J.-F., Chapelle, J.-P., & Lutteri, L. (January 2008). Comment j'explore... Revue des principaux auto-anticorps. Revue Médicale de Liège, 63 (1), 43-9.
Peer reviewed

Delanaye, P., Cavalier, E., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2008). New data on the intraindividual variation of cystatin C. Nephron. Clinical Practice, 108 (4), 246-8. doi:10.1159/000124327
Peer Reviewed verified by ORBi

Mistretta, V., Delanaye, P., Chapelle, J.-P., Souberbielle, J.-C., & Cavalier, E. (2008). Vitamine D2 ou vitamine D3? Revue de Médecine Interne, 29 (10), 815-20. doi:10.1016/j.revmed.2008.03.003
Peer Reviewed verified by ORBi

Piéroni, L., Delanaye, P., Abshoff, C., Lutteri, L., Chapelle, J.-P., Hainque, B., Krzesinski, J.-M., & Cavalier, E. (2008). Impact de la stabilité de la cystatine C sur la validité des mesures dans les études rétrospectives [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Chau, T.-L., Gioia, R., GATOT, J.-S., Patrascu, F. A., Carpentier, I., Chapelle, J.-P., O'Neill, L., Beyaert, R., Piette, J., & Chariot, A. (2008). Are the IKKs and IKK-related kinases TBK1 and IKK-ε similarly activated ? Trends in Biochemical Sciences, 33, 171-180. doi:10.1016/j.tibs.2008.01.002
Peer Reviewed verified by ORBi

Cavalier, E., Carlisi, A., Chapelle, J.-P., & Delanaye, P. (January 2008). False positive PTH results: An easy strategy to test and detect analytical interferences in routine practice. Clinica Chimica Acta, 387 (1-2), 150-152. doi:10.1016/j.cca.2007.08.019
Peer Reviewed verified by ORBi

Cavalier, E., Rozet, E., Dubois, N., Charlier, C., Hubert, P., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (2008). Performance of iohexol determination in serum and urine by HPLC: validation, risk and uncertainty assessment. Clinica Chimica Acta, 396, 80-85. doi:10.1016/j.cca.2008.07.011
Peer Reviewed verified by ORBi

Meuwis, M.-A., Fillet, M., Chapelle, J.-P., Malaise, M., Louis, E., & Merville, M.-P. (2008). New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools. Expert Review of Molecular Diagnostics, 8, 327-37. doi:10.1586/14737159.8.3.327
Peer Reviewed verified by ORBi

Lognard, M., Cavalier, E., Chapelle, J.-P., Lambermont, B., Krzesinski, J.-M., & Delanaye, P. (19 December 2007). Acetylcysteine and Enzymatic Creatinine: Beware of Laboratory Artefact! [letter to the editor]. Intensive Care Medicine, 34 (5), 973-974. doi:10.1007/s00134-007-0972-9
Peer Reviewed verified by ORBi

Le Goff, C., Bovy, C., Aldenhoff, M.-C., Krzesinski, J.-M., & Chapelle, J.-P. (December 2007). Intérêt pronostique à trois ans de la troponine T cardiaque (cTnT) et du fragment N-terminal du propeptide du peptide natriurétique de type B (NT-proBNP) chez les patients hémodialysés. Immuno-Analyse and Biologie Spécialisée, 22 (6), 377-383. doi:10.1016/j.immbio.2007.09.002
Peer reviewed

Katsanos, K., Cavalier, E., Ferrante, M., Schnitzler, F., Katsaraki, A., Noman, M., Vermeire, S., Epameinondas, V. T., Rutgeerts, P., Chapelle, J.-P., & Van Assche, G. (December 2007). Intravenous iron therapy restores functional iron deficiency induced by infliximab. Journal of Crohn's and Colitis, 1, 97-105. doi:10.1016/j.crohns.2007.08.005
Peer Reviewed verified by ORBi

Gioia, R., GATOT, J.-S., Chau, T.-L., Warnier, M., Chapelle, J.-P., Piette, J., Dejardin, E., & Chariot, A. (December 2007). Insight into the TBK1/IKK-dependent signalling pathways required in innate immunity through identification of the TANK/I-TRAF interactome [Poster presentation]. Journée Télévie, ULB GOsselies, Belgium.

Le Goff, C., Chapelle, J.-P., & Lutteri, L. (November 2007). Comparaison de cinq techniques de détection des anticorps anti-saccharomyces cerevisae (ASCA) dans le sérum pour le diagnostic de la maladie de Crohn. Annales de Biologie Clinique, 65 (6), 601-608.
Peer Reviewed verified by ORBi

GATOT, J.-S., Gioia, R., Chau, T.-L., Patrascu, F. A., Warnier, M., Close, P., Chapelle, J.-P., Muraille, E., Brown, K., Siebenlist, U., Piette, J., Dejardin, E., & Chariot, A. (26 October 2007). Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKK epsilon-dependent lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. Journal of Biological Chemistry, 282 (43), 31131-31146. doi:10.1074/jbc.M701690200
Peer Reviewed verified by ORBi

Chapelle, J.-P. (25 October 2007). La procalcitonine: un marqueurs d'infection bactérienne [Paper presentation]. BioMérieux Workshop, Colonster, Sart Tilman, Liège, Belgium.

Haleng, J., Pincemail, J., Defraigne, J.-O., Charlier, C., & Chapelle, J.-P. (October 2007). Le stress oxydant. Revue Médicale de Liège, 62 (10), 628-38.
Peer reviewed

Pincemail, J., Haleng, J., Le Goff, C., Charlier, C., Chapelle, J.-P., & Defraigne, J.-O. (2007). Stress oxydant : comment évaluer le statut du patient? Nutrition Infos, (oct/nov/déc), 47-50.
Peer reviewed

Le Goff, C., Chapelle, J.-P., & Lutteri, L. (October 2007). Comparison of first and second generation m2-ELISA in primary biliary cirrhosis'diagnosis [Poster presentation]. Symposium de la Société Belge de Biologie clinique, Bruxelles, ULB, Belgium.

Chapelle, J.-P. (20 September 2007). Utilisation des dosages de procalcitonine pour le monitoring de l'antibiothérapie: mythe ou réalité [Paper presentation]. Réunion du GLEM Biologie clinique, Liège, Belgium.

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (September 2007). Impact des conditions préanalytiques sur le dosage de la PTH. Néphrologie et Thérapeutique, 3 (5), 192.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, A., Krzesinski, J.-M., & Chapelle, J.-P. (August 2007). Stability of intact parathyroid hormone in samples from hemodialysis patients. Kidney International, 72 (3), 370-372. doi:10.1038/sj.ki.5002363
Peer Reviewed verified by ORBi

Pincemail, J., Vanbelle, S., Gaspard, U., Collette, G., Haleng, J., Cheramy-Bien, J. P., Charlier, C., Chapelle, J.-P., Giet, D., Albert, A., Limet, R., & Defraigne, J.-O. (August 2007). Effect of different contraceptive methods on the oxidative stress status in women aged 40-48 years from the ELAN study in the province of Liege, Belgium. Human Reproduction, 22 (8), 2335-2343. doi:10.1093/humrep/dem146
Peer Reviewed verified by ORBi

Ledoux, D., Monchi, M., Chapelle, J.-P., & Damas, P. (August 2007). Cystatin C blood level as a risk factor for death after heart surgery. European Heart Journal, 28 (15), 1848-53. doi:10.1093/eurheartj/ehm270
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). PTH stability : preanalytical conditios influences for Liaison (Diasorin). Clinical Chemistry and Laboratory Medicine, 45.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). Evaluation of heterophile antibodies interference on Liaison PTH (Diasorin). Clinical Chemistry and Laboratory Medicine, 45.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (April 2007). Analytical variation in plasma renin activity: Implications for the screening of primary aldosteronism [letter to the editor]. Clinical Chemistry, 53 (4), 803-804. doi:10.1373/clinchem.2006.083600
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (23 March 2007). MDRD equation for GFR estimation : analytical limitations [Paper presentation]. 10th International Symposium of Nephrology at Montecatini, Montecatini Terme, Italy.

Delanaye, P., Nellessen, E., Cavalier, E., Depas, G., Grosch, S., Defraigne, J.-O., Chapelle, J.-P., Krzesinski, J.-M., & Lancellotti, P. (15 March 2007). Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant patients? Transplantation, 83 (5), 641-644. doi:10.1097/01.tp.0000253746.30273.cd
Peer Reviewed verified by ORBi

Creppe, C., Close, P., Cornez, I., Rahmouni, S., Merville, M.-P., Chapelle, J.-P., Nusgens, C., Deroanne, C., & Chariot, A. (March 2007). A role for the transcriptional complex elongator in cell migration and spreading [Poster presentation]. Colloque "Chromatin Dynamics and Epigenetics" Société belge de biologie cellulaire et du développement, Liège, Belgium.

GATOT, J.-S., Gioia, R., Chau, T.-L., Warnier, M., Chapelle, J.-P., Merville, M.-P., Brown, K., Siebenlist, U., Muraille, E., Dejardin, E., Piette, J., & Chariot, A. (March 2007). Polyubiquitination of the scaffold protein tank/I-traf: implications for the TLR-mediated signalling pathways [Poster presentation]. Colloque "Chromatin Dynamics and Epigenetics" Société belge de biologie cellulaire et du développement, Liège, Belgium.

Cavalier, E., Delanaye, P., Ferir, A.-M., Krzesinski, J.-M., & Chapelle, J.-P. (February 2007). Measurement uncertainty of creatinine in low values: Another good reason not to use the MDRD formula with low creatinine values. Clinical Biochemistry, 40 (3-4), 285-286. doi:10.1016/j.clinbiochem.2006.10.021
Peer Reviewed verified by ORBi

Lutteri, L., Malaise, M., & Chapelle, J.-P. (2007). Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. Clinica Chimica Acta, 386 (1-2), 76-81. doi:10.1016/j.cca.2007.08.002
Peer Reviewed verified by ORBi

Gach, O., Legrand, V., Biessaux, Y., Chapelle, J.-P., Vanbelle, S., & Pierard, L. (01 January 2007). Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. American Journal of Cardiology, 99 (1), 31-35. doi:10.1016/j.amjcard.2006.07.059
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, I., Rogister, C., Mourad, I., Krzesinski, J.-M., & Chapelle, J.-P. (2007). High prevalence of vitamin D deficiency in pregnant women and new mothers in the area of Liège, Belgium [Poster presentation]. 17th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Amsterdam, Netherlands.

Delanaye, P., Cavalier, E., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2007). Variabilité du débit de filtration glomérulaire, de la créatinine et de la cystatine C plasmatiques [Poster presentation]. 9ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

Lognard, M., Cavalier, E., Chapelle, J.-P., Lambermont, B., Krzesinski, J.-M., & Delanaye, P. (2007). Acetylcysteine and enzymatic creatinine: take care for interference! Acta Clinica Belgica, 62 (6), 462-462.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (2007). Evaluation multiparamétrique du risque cardiaque dans les syndromes coronariens aigus: intérêt des marqueurs biologiques sanguins. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 162 (3-4), 207-215.
Peer Reviewed verified by ORBi

Goffinet, J., Bernard, P., Cavalier, E., & Chapelle, J.-P. (2007). Evaluation of the new BRAHMS-Biomerieux quantitative test for procalcitonin determination. Acta Clinica Belgica, 62 (6), 463-463.
Peer Reviewed verified by ORBi

Cavalier, E., Delanaye, P., Carlisi, A., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Analytical validation of the new version of the Liaison N-Tact PTH assay. Clinical Chemistry and Laboratory Medicine, 45 (1), 105-107. doi:10.1515/CCLM.2007.017
Peer Reviewed verified by ORBi

Meuwis, M.-A.* , Fillet, M.* , Geurts, P., De Seny, D., Lutteri, L., Chapelle, J.-P., Bours, V., Wehenkel, L., Belaiche, J., Malaise, M., Louis, E., & Merville, M.-P. (2007). Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochemical Pharmacology, 73 (9), 1422-1433. doi:10.1016/j.bcp.2006.12.019
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Stability of intact parathormone in hemodialyzed patients: a pragmatic study on Roche Elecsys assay [Poster presentation]. Réunion de la Société Belge de Néphrologie, Brussels, Belgium.

Le Goff, C., Aldenhoff, M.-C., Bovy, C., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Interest of plasma NT-proBNP determinations for 3-year prognosis in hemodialyzed patients [Poster presentation]. 17th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Amsterdam, Netherlands.

Le Goff, C., Lutteri, L., & Chapelle, J.-P. (2007). Detection of ASCA and the diagnosis of crohn's disease [Poster presentation]. 17 IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Amsterdam, Netherlands.

Teixeira, J., Aldenhoff, M.-C., & Chapelle, J.-P. (2007). Analytical and Clinical Evaluation of the New Tosoh G8 Analyser for HbA1c Measurement. Acta Clinica Belgica, 62-6.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (23 November 2006). Standardisation du dosage des troponines cardiaques dans le sang [Paper presentation]. Colloque: Nouveaux marqueurs cardiaques: troponines et peptides natriurétiques, Bruxelles, Belgium.

Delanaye, P., Cavalier, E., Chapelle, J.-P., Krzesinski, J.-M., & Froissart, M. (November 2006). Renal extraction of cystatin C [letter to the editor]. Nephrology Dialysis Transplantation, 21 (11), 3333-3333. doi:10.1093/ndt/gfl324
Peer Reviewed verified by ORBi

Le Goff, C., Aldenhoff, M.-C., Bovy, C., Krzesinski, J.-M., & Chapelle, J.-P. (26 October 2006). Interest of cTnT and NT-proBNP for 3-year prognosis in hemodialyzed patients [Paper presentation]. CORATA, Brugges, Belgium.

Chapelle, J.-P. (26 October 2006). La procalcitonine: aspects biochimiques et analytiques [Paper presentation]. 23ème colloque: actualités en Immunoanalyse et Biologie spécialisée, Bruges, Belgium.

Chapelle, J.-P. (25 October 2006). Intérêt des biomarqueurs dans les syndromes coronariens aigus [Paper presentation]. 23ème colloque : actualités en Immunoanalyse et Biologie spécialisée, Bruges, Belgium.

Cavalier, E., Levaux, L., Carlisi, I., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2006). VALIDATION ANALYTIQUE DE LA TROUSSE OCTEIA 25-HYDROXYVITAMINE D (IDS). Immuno-Analyse and Biologie Spécialisée.
Peer reviewed

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (2006). PTH oxidation after a session of hemodialyze: myth or reality? Immuno-Analyse and Biologie Spécialisée.
Peer reviewed

Katsanos, K., Cavalier, E., Ferrante, M., Van Hauwaert, V., Henckaerts, L., Schnitzler, F., Katsaraki, A., Noman, M., Vermeire, S., Epameinondas, V. T., Rutgeers, P., Chapelle, J.-P., & Van Assche, G. (October 2006). The effect of I.V. iron sucrose therapy on erythropoietin and soluble transferring receptor levels in Crohn’s disease patients treated with Infliximab [Poster presentation]. 14th European Gastroenterology week, Berlin, Germany.

Cavalier, E., Delanaye, P., Collette, J., Krzesinski, J.-M., & Chapelle, J.-P. (September 2006). Evaluation of different bone markers in hemodialyzed patients. Clinica Chimica Acta, 371 (1-2), 107-111. doi:10.1016/j.cca.2006.02.029
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Krzesinski, J.-M., & Chapelle, J.-P. (August 2006). Why the MDRD equation should not be used in patients with normal renal function (and normal creatinine values)? [letter to the editor]. Clinical Nephrology, 66 (2), 147-148. doi:10.5414/cnp66147
Peer Reviewed verified by ORBi

Chapelle, J.-P. (03 May 2006). L'accès du pharmacien à la spécialisation en biologie clinique [Paper presentation]. Journée d'information sur les carrières pharmaceutiques, Colonster, Sart Tilman, Liège, Belgium.

Delanaye, P., Cavalier, E., Chapelle, J.-P., & Krzesinski, J.-M. (April 2006). Importance of the creatinine calibration in the estimation of GFR by MDRD equation [letter to the editor]. Nephrology Dialysis Transplantation, 21 (4), 1130-1130. doi:10.1093/ndt/gfl038
Peer Reviewed verified by ORBi

Chapelle, J.-P. (17 March 2006). Intérêt de la détermination conjointe des troponines cardiaques et du BNP dans les syndromes coronariens aigus [Paper presentation]. Xème Colloque de Biologie Prospective INTERREG IIIA, Nancy, France.

Le Goff, C., Da silva, A., & Chapelle, J.-P. (16 March 2006). Comparaison des dosages de BNP et NT-proBNP dans l'insuffisance cardiaque [Poster presentation]. Xème colloque de biologie prospective, Nancy, France.

Le Goff, C., Lutteri, L., & Chapelle, J.-P. (16 March 2006). Les anticorps anti-saccharomyces cerevisiae: comment les rechercher? [Poster presentation]. EUROBIOLOGIE, Nancy, France.

Meex, C., Poncin, J., Chapelle, J.-P., & Cavalier, E. (2006). Analytical validation of the new plasma calibrated Accu-Chek (R) Test Strips (Roche Diagnostics). Clinical Chemistry and Laboratory Medicine, 44 (11), 1376-1378. doi:10.1515/CCLM.2006.249
Peer Reviewed verified by ORBi

Gach, O., Nys, M., Deby, G., Chapelle, J.-P., Lamy, M., Pierard, L., & Legrand, V. (2006). Acute neutrophil activation in direct stenting: comparison of stable and unstable angina patients. International Journal of Cardiology, 112 (1), 59-65. doi:10.1016/j.ijcard.2005.09.010
Peer Reviewed verified by ORBi

Delanaye, P., Cavalier, E., Radermecker, R., Rorive, M., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2006). Plasma cystatin C for the detection of renal failure in obese patients [Poster presentation]. 43ème Congress of ERA-EDTA, Glasgow, United Kingdom.

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2006). Estimation du débit de filtration glomérulaire par les formules basées sur la créatinine et la cystatine C en cas d’anorexie mentale [Paper presentation]. 8éme réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lille, France.

Cavalier, E., Carlisi, A., & Chapelle, J.-P. (2006). Validation analytique de l'ImmunoCap 250 (Sweden Diagnostics). Annales de Biologie Clinique, 64 (1, Jan-Feb), 91-4.
Peer Reviewed verified by ORBi

Delanaye, P., Nellessen, E., Grosch, S., Depas, G., Cavalier, E., Defraigne, J.-O., Chapelle, J.-P., Krzesinski, J.-M., & Lancellotti, P. (2006). Creatinine-based formulae for the estimation of glomerular filtration rate in heart transplant recipients. Clinical Transplantation, 20 (5, Sep-Oct), 596-603. doi:10.1111/j.1399-0012.2006.00523.x
Peer Reviewed verified by ORBi

Bonif, M., Meuwis, M.-A., Close, P., Benoit, V., Heyninck, K., Chapelle, J.-P., Bours, V., Merville, M.-P., Piette, J., Beyaert, R., & Chariot, A. (2006). TNFa and IKKb-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKg and NF-kB activation. Biochemical Journal, 394, 593-603. doi:10.1042/BJ20051659
Peer Reviewed verified by ORBi

Chapelle, J.-P., & Libeer, J. C. (17 November 2005). Valeurs de référence: comment les établir? Comment les vérifier? [Paper presentation]. Formation continue en Biologie clinique, Colonster CHU, Belgium.

Lutteri, L., Malaise, M., & Chapelle, J.-P. (27 October 2005). Evaluation of the new Elisa CCp assay on unicap 100 [Poster presentation]. Annual Symposium of the Belgian Societies of Clinical Chemistry and Clinical Biology, Liège, Belgium.

Chapelle, J.-P., & Cavalier, E. (14 September 2005). Traitement des plaintes dans un système d'assurance qualité: l'expérience du laboratoire de Biologie clinique [Paper presentation]. Symposium: la qualité dans les laboratoires en Belgique, Liège, Belgium.

Chapelle, J.-P. (09 June 2005). Marqueurs cardiaques. Utilisation des troponines en combinaison avec d'autres biomarqueurs dans les syndromes coronariens aigus [Paper presentation]. Réunion de la Société Luxembourgeoise de Biologie clinique, Luxembourg.

Chapelle, J.-P. (31 May 2005). Les marqueurs cardiaques dans les syndromes coronariens aigus [Paper presentation]. Bio-workshop Biomérieux, Liège, Belgium.

Meex, C., Cavalier, E., Poncin, J., & Chapelle, J.-P. (May 2005). Analytical validation of the new plasma calibrated Accu-Check test strips (Roche Diagnostics) [Poster presentation]. 28th National Symposium of the SBCC, Liège, Belgium.

Deberg, M., Labasse, A., Christgau, S., Cloos, P., Bang Henriksen, D., Chapelle, J.-P., Zegels, B., Reginster, J.-Y., & Henrotin, Y. (March 2005). New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis and Cartilage, 13 (3), 258-265. doi:10.1016/j.joca.2004.12.002
Peer Reviewed verified by ORBi

Gach, O., Biemar, C., Nys, M., Deby-Dupont, G., Chapelle, J.-P., Deby, C., Lamy, M., Pierard, L., & Legrand, V. (February 2005). Early release of neutrophil markers of activation after direct stenting in patients with unstable angina. Coronary Artery Disease, 16 (1), 59-65. doi:10.1097/00019501-200502000-00011
Peer Reviewed verified by ORBi

Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2005). Impact des différences dans les techniques de calibration de la créatinine sérique sur les résultats de la formule de Cockcroft et du MDRD [Poster presentation]. 7ème réunion commune de la Société de Néphrologie et de la société Française de Dialyse, Clermont-Ferrand, France.

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2005). Comparison of liaison N-tact PTH (diasorin) and N-tact PTH SPIRMA (diasorin) in hemodialyzed patients [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 43 (8), 890-891. doi:10.1515/CCLM.2005.151
Peer Reviewed verified by ORBi

Lutteri, L., Malaise, M., & Chapelle, J.-P. (09 October 2004). In rheumatoid arthritis, anti-citrullinated peptides antibodies are concentrated in synovial fluid [Poster presentation]. Symposium de la Société Belge de Biologie Clinique, Belgium.

Cavalier, E., Carlisi, I., Delanaye, P., Pazzaglia, G., Krzesinski, J.-M., & Chapelle, J.-P. (October 2004). Comparaison of liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients [Poster presentation]. 21ème Colloque CORATA, Paris, France.

Chapelle, J.-P. (19 September 2004). Laboratory testing of plasma troponin I and T for point-of care diagnosis and classification of acute coronary syndromes [Paper presentation]. Third European Symposium on thromboembolic diseases, Utrecht, Netherlands.

Pagani, F., Stefini, F., Chapelle, J.-P., Lefevre, G., Graine, H., Luthe, H., Engelmayer, J., & Panteghini, M. (September 2004). Multicenter evaluation of analytical performance of the Liaison((R)) troponin I assay. Clinical Biochemistry, 37 (9), 750-757. doi:10.1016/j.clinbiochem.2004.04.003
Peer Reviewed verified by ORBi

Delanaye, P., Lambermont, B., Chapelle, J.-P., Gielen, J., Gérard, P., & Rorive, G. (May 2004). Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Medicine, 30 (5), 980-983. doi:10.1007/s00134-004-2189-5
Peer Reviewed verified by ORBi

Chapelle, J.-P. (May 2004). Stratification du risque dans les syndromes coronariens aigus au moyen des troponines cardiaques et des peptides natriurétiques [Paper presentation]. Xth Arab Congress of Clinical Biology, Monastir, Tunisia.

Delanaye, P., Radermecker, R., Saint-Remy, A., Depas, G., Chapelle, J.-P., Gielen, J., Scheen, A., & Krzesinski, J.-M. (2004). Estimation of renal function in anorexia nervosa [Poster presentation]. Réunion de la Société Belge de Néphrologie, Liège, Belgium.

Delanaye, P., Radermecker, R., Saint-Remy, A., Chapelle, J.-P., Depas, G., Foidart, J., Gielen, J., Scheen, A., & Krzesinski, J.-M. (2004). Estimation de la fonction rénale chez le patient anorexique [Poster presentation]. Congrès annuel de l’ALFEDIAM, Nice, France.

Delanaye, P., Radermecker, R., Rorive, M., Depas, G., Chapelle, J.-P., Gielen, J., & Krzesinski, J.-M. (2004). Detection of renal failure in overweight patients [Poster presentation]. Réunion de la Société Belge de Néphrologie, Liège, Belgium.

Delanaye, P., Nellessen, E., Grosch, S., Depas, G., Chapelle, J.-P., Gielen, J., Foidart, J., Krzesinski, J.-M., & Lancellotti, P. (2004). Is plasme cystatin C better than creatinine to detect renal failure in heart transplant recipients? [Paper presentation]. 41ème Congress of ERA-EDTA, Lisbonne, Portugal.

Delanaye, P., Saint-Remy, A., Nellessen, E., Grosch, S., Depas, G., Chapelle, J.-P., Gielen, J., Krzesinski, J.-M., & Lancellotti, P. (2004). New methods for the detection and estimation of renal function in heart transplant recipients [Paper presentation]. Meeting of the Belgian Transplantation Society, Bruxelles, Belgium.

Chapelle, J.-P. (11 December 2003). Les marqueurs de la décompensation cardiaque [Paper presentation]. Symposium: les marqueurs de la décompensation cardiaque, Fleurus, Belgium.

Chapelle, J.-P. (08 December 2003). Intérêt de la mesure du peptide natriuretique de type B (BNP) en Biologie clinique [Paper presentation]. Réunion du GLEM 489, CHU Liège, Sart Tilman, Liège, Belgium.

Camus, G., Croisier, J.-L., Chapelle, J.-P., Deby-Dupont, G., Deby, C., Crielaard, J.-M., & Lamy, M. (November 2003). Activation of circulating polymorphonuclear neutrophils during exercise-induced muscle damage. Pflugers Arch – Eur J Physiol, 447, 9.
Peer reviewed

Chapelle, J.-P. (02 October 2003). Le contrôle de qualité interne dans le laboratoire de Biologie clinique [Paper presentation]. Workshop BIO-RAD, Ottignies-Louvain-La-Neuve, Belgium.

Chapelle, J.-P. (October 2003). Multimarker approach to risk stratification [Paper presentation]. Euregio Congress of Clinical Chemistry and Laboratory Medicine, Aachen, Germany.

Chapelle, J.-P. (18 September 2003). Intérêt du BNP pour le diagnostic, le pronostic et le suivi thérapeutique de l'insuffisance cardiaque [Paper presentation]. Advia Centaur users group meeting, Brussels, Belgium.

Chapelle, J.-P., Aldenhoff, M.-C., & Gielen, J. (June 2003). The use of the TOSOH AIA-600II and AIA-1800 immunoassay analyzers for the determination of cTnI [Paper presentation]. 15th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Barcelone, Spain.

Chapelle, J.-P., Aldenhoff, M.-C., Pincemail, J., & Gielen, J. (June 2003). Evaluation of the new Tosoh cardiac troponin I assay on AIA 600II. Application to myocardial damage detection in semi-marathon and triathlon runners [Poster presentation]. 15th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Barcelone, Spain.

Chapelle, J.-P. (09 May 2003). Contrôle de qualité interne: aspects pratiques [Paper presentation]. Séance de formation continue du Département de Biologie clinique, Sart Tilman, Liège, Belgium.

Chapelle, J.-P. (April 2003). Myocardial injury of non ischemic etiology: a new era of troponin I assay application [Paper presentation]. Incontro Nazionale: La troponina I cardiaca: attualita a prospettive, Roma, Italy.

Chapelle, J.-P. (12 March 2003). Les paramètres statistiques du QC interne et leur utilisation pour évaluer la qualité des analyses [Paper presentation]. Workshop QC interne, Haine-Saint-Paul, Belgium.

Delanaye, P., Chapelle, J.-P., Ferir, A.-M., Gielen, J.-L., Krzesinski, J.-M., & Rorive, G. (February 2003). La mesure du débit de filtration glomérulaire en clinique quotidienne. Revue Médicale de Liège, 58 (2), 95-100.
Peer reviewed

Goffinet, J., Bodson, Q., Chapelle, J.-P., Gielen, J., & Ferir, A. M. (2003). Influence of Hyperbilirubinemia on Spectrophotometric Measurement of 30 Biochemical Tests, using the Roche® Modular P-module. Clinical Chemistry and Laboratory Medicine, 41, 88-89.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Aldenhoff, M.-C., Pincemail, J., & Gielen, J. (2003). Evaluation of the nex Tosoh cardiac troponin I assay on AIA-600II. Application to myocardial damage detection in semi-marathon and triathlon runners. Clinical Chemistry and Laboratory Medicine, 41, 5414.
Peer Reviewed verified by ORBi

Delanaye, P., Lambermont, B., Chapelle, J.-P., Gielen, J., & Rorive, G. (2003). Intérêt de la cystatine C dans l’évaluation de la fonction rénale chez le patient hospitalisé aux soins intensifs [Poster presentation]. 31ème congrès de la Société de Réanimation de Langue Française, Paris, France.

Chapelle, J.-P., Aldenhoff, M.-C., & Gielen, J. (2003). The use of the Tosoh AIA-600II and AIA-1800 immunoassay analysers for the determination of CTNI. Clinical Chemistry and Laboratory Medicine, 41, 571.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (2003). Multimarker approach to risk stratification. Clinical Chemistry and Laboratory Medicine, 41, 79.
Peer Reviewed verified by ORBi

Delanaye, P., Chapelle, J.-P., Gielen, J., Krzesinski, J.-M., & Rorive, G. (2003). L'intérêt de la cystatine C dans l'évaluation de la fonction rénale. Nephrologie, 24 (8), 457-68.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (13 November 2002). Contrôle de qualité interne/Les règles de Westgard [Paper presentation]. Workshop: assurance qualité des laboratoires, Namur, Belgium.

Chapelle, J.-P. (07 November 2002). Comparaison des troponines I et T cardiaques dans les syndromes coronariens aigus [Paper presentation]. Symposium: Les marqueurs cardiaques en 2002, Paris, France.

Chapelle, J.-P. (08 October 2002). Clinical applications of plasma troponin I and troponin T measurements in patients with acute coronary syndroms [Paper presentation]. Benelux symposium: new approaches in the diagnosis and management of venous and arteriel trombosis, Breda, Netherlands.

Chapelle, J.-P. (25 September 2002). Contrôle de qualité interne: aspects statistiques [Paper presentation]. Workshop: assurance qualité des laboratoires, Nimy (Mons), Belgium.

Chapelle, J.-P., & Legrand, V. (26 June 2002). Apports des troponines au diagnostic et traitement des cardiopathies ischémiques [Paper presentation]. Colloque: Biologie prospective, Nancy, France.

Chapelle, J.-P. (16 May 2002). Les adducts à l'hémoglobine et aux protéines [Paper presentation]. Séance de formation continue du Département de Biologie clinique du CHU, Sart Tilman, Liège, Belgium.

Chapelle, J.-P. (17 January 2002). Mise en place de l'assurance qualité dans les laboratoires de biologie clinique en Belgique [Paper presentation]. Symposium: qualité dans les laboratoires, Luxembourg.

Chapelle, J.-P., Dubois, B., Bovy, C., Aldenhoff, M.-C., Gielen, J., & Rorive, G. (2002). Comparison of plasma cardiac troponins T and I in chronically hemodialyzed patients in relation to cardiac status and age. Clinical Chemistry and Laboratory Medicine, 40 (3), 240-245. doi:10.1515/CCLM.2002.039
Peer Reviewed verified by ORBi

Chapelle, J.-P. (December 2001). Systèmes d'assurance de qulaité dans le cadre des laboratoires de chimie médicale [Paper presentation]. Journées "Contrôle - Assurance qualité", Bruxelles, Belgium.

Chapelle, J.-P. (15 November 2001). Actualités sur la procalcitonine [Paper presentation]. Journée de la Société luxembourgeoise de Biologie clinique, Walferdange, Luxembourg.

Chapelle, J.-P. (27 October 2001). Clinical applications of cardiac troponins [Paper presentation]. Symposium national des Sociétés Belges de Biologie clinique et de Chimie clinique, Bruxelles, Belgium.

Chapelle, J.-P., & Libeer, J. C. (25 October 2001). Le rôle du coordinateur qualité dans le laboratoires de Biologie clinique [Paper presentation]. L'assurance qualité en Biologie clinique, Bruxelles, Belgium.

Chapelle, J.-P. (19 June 2001). Cardiac troponins in patients with chronic renal failure [Paper presentation]. Workshop: Clinical applications of cardiac markers, Bruxelles, Belgium.

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (May 2001). Association between lipoprotein (A) and cardiac troponins in PTCA patients [Poster presentation]. 14th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Prague, Czechia.

Chapelle, J.-P. (May 2001). Are cardiac markers useful in patients with chronic renal failure? [Paper presentation]. 14th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Prague, Czechia.

Camus, G., Rongé-Collard, E., Nys, M., Venneman, I., Chapelle, J.-P., Mouithys-Mickalad, A., Deby-Dupont, G., Deby, C., & Lamy, M. (May 2001). Marqueurs humoraux d'activation de l'endothélium vascualire et des polymorphonucléaires neutrophiles circulants lors de l'exercice intense [Poster presentation]. 3ème Colloque "Biologie de l'exercice musculaire", Clermont-Ferrand, France.

Chapelle, J.-P. (03 April 2001). Procalcitonine: aspects biochimiques et analytiques [Paper presentation]. Séance de formation continue du Département de Biologie clinique CHU, Sart Tilman, Liège, Belgium.

Chapelle, J.-P. (25 January 2001). Actualités sur les marqueurs biochimiques des pathologies coronariennes ischémiques: stratégie de choix et d'interprétation.

Chapelle, J.-P. (2001). Are cardiac markers useful in patients with chronic renal failure? Clinical Chemistry and Laboratory Medicine, 39 (suppl), 36.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (2001). Clinical applications of cardiac troponins. Acta Clinica Belgica, 56, 323.
Peer Reviewed verified by ORBi

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (2001). Association between lipoprotein (A) and cardiac troponins in PTCA patients. Clinical Chemistry and Laboratory Medicine, 39 (suppl), 278.
Peer Reviewed verified by ORBi

Servais, P., Nys, M., Canivet, J.-L., Ledoux, D., Monchi, M., Chapelle, J.-P., & Damas, P. (2001). Relationship between procalcitonin plasma level and severity of infection. Intensive Care Medicine, 27 (suppl.), 560.
Peer Reviewed verified by ORBi

Lutteri, L., Legrand, V., Gielen, J., & Chapelle, J.-P. (2001). Relationship between lipoprotein (a) and cardiac troponins in PTCA patients. Acta Clinica Belgica, 56, 325.
Peer Reviewed verified by ORBi

Pincemail, J., Bovy, C., Chapelle, J.-P., Gielen, J., Defraigne, J., & Rorive, G. (2001). Markers of oxidative stress limited to increased risk of cardiovascular disease in chronic hemodialysis patients. Free Radical Biology and Medicine, 31 (suppl), 345.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Legrand, V., Lutteri, L., & Gielen, J. (2001). Cardiac troponin I and T concentrations are related to plasma lipoprotein (a) levels in PTCA patients. European Heart Journal, 22, 209.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (12 December 2000). Accréditation et agrément des laboratoires de Biologie clinique [Paper presentation]. Conférence des hôpitaux académiques de Belgique, Hôpital Erasme, Anderlecht, Belgium.

Bordas-Fonfrede, M., Selam, J. L., Goudable, J., Thivolet, C., Vialettes, B., Chapelle, J.-P., Drouin, P., Hue, G., Levy-Marchal, C., Slama, G., & Gillery, P. (December 2000). Considerations on delocalized HbA(1c) assays. Diabetes and Metabolism, 26 (6), 508-512.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (06 November 2000). La troponine, nouveau marqueur de l'infarctus du myocarde [Paper presentation]. Colloquium: merkers bij cardiovascular lijden, KHBO, Campus St Michiel, Brugge, Belgium.

Chapelle, J.-P., Aldenhoff, M.-C., Pierard, L., & Gielen, J. (November 2000). Comparison of cardiac troponin I measurements on whole blood and plasma on the Stratus CS analyzer and comparison with AxSYM. Clinical Chemistry, 46 (11), 1864-6. doi:10.1093/clinchem/46.11.1864
Peer Reviewed verified by ORBi

Chapelle, J.-P., Aldenhoff, M.-C., Pierard, L., & Gielen, J. (28 October 2000). Comparison of the stratus CS and Axsym analyzers for the determination of cardiac troponin I in plasma [Poster presentation]. National Symposium of the Belgian Society of Clinical Biology, Ghent, Belgium.

Chapelle, J.-P., & Legrand, V. (October 2000). Marqueurs cardiaques: stratégie d'utilisation et d'interprétation [Paper presentation]. 17ème colloque en Immunoanalyse et Biologie spécialisée, Poitiers, France.

Chapelle, J.-P. (26 September 2000). Quality assurance: experience of an university [Paper presentation]. Colloquium: implementation of a quality system in the clinical laboratory: pratical aspects, Woluwe, Belgium.

Gillery, P., Hue, G., Bordas-Fonfrède, M., Chapelle, J.-P., Drouin, P., Lévy-Marchal, C., Périer, C., Sélam, J.-L., Thivolet, C., & Vialettes, B. (August 2000). Dosage de l'hémoglobine A1C et hémoglobinopathies : problèmes posés et conduite à tenir. Annales de Biologie Clinique, 58 (4), 425-9.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (11 May 2000). Les troponines: avantages analytiques et diagnostiques [Paper presentation]. Symposium: Cardiale troponines: analytische en diagnostische mogelijkheden en beperkingen, Bruxelles, Belgium.

Chapelle, J.-P., Biessaux, Y., Legrand, V., & Gielen, J. (April 2000). Prognostic significance of increased baseline plasma troponin I levels in PTCA patients [Poster presentation]. European Conference on Management of Coronary Heart Disease, Nice, France.

Pirnay, F., Spadin, D., Croisier, J.-L., Nivelle, F., & Chapelle, J.-P. (01 April 2000). Marqueurs biologiques de souffrance musculaire et cardiaque pendant des contractions excentriques [Poster presentation]. Vergadering van de Belgische vereniging voor sportwetenschappen VUB, Belgium.

Chapelle, J.-P. (20 March 2000). Accréditation des laboratoires de Biologie clinique [Paper presentation]. Réunion GLEM 0489, Sart Tilman, Liège, Belgium.

Chapelle, J.-P. (March 2000). Intérêt de la CRPus dans l'angioplastie transluminale [Paper presentation]. Symposium on plasma proteins, Sevilla, Spain.

Chapelle, J.-P., Melin, P., & Philippe, M. (10 February 2000). Place des examens d'urine dans la biologie clinique actuelle [Paper presentation]. Formation continue en Biologie clinique, CHU Liège, Liège, Belgium.

Lutteri, L., Chapelle, J.-P., Legrand, V., & Gielen, J. (22 January 2000). Hyperhomocysteinemia and cardiovascular risk in PTCA patients [Poster presentation]. Congrès Orbita 2000, Genval, Belgium.

Chapelle, J.-P., Legrand, V., & Gielen, J. (2000). Prognostic significance of increased baseline plasma troponin I levels in PTCA patients. Clinical Chemistry, 46 (suppl), 82.
Peer Reviewed verified by ORBi

Pirnay, F., Spadin, D., Croisier, J.-L., Nivelle, F., & Chapelle, J.-P. (2000). Marqueurs biologiques de souffrance musculaire et cardiaque pendant des contractions excentriques. In Actes de la Réunion Annuelle de la Société Belge de la Médecine et des Sciences du Sport.

Chapelle, J.-P. (January 2000). Cardiac markers: an update [Paper presentation]. BioMérieux International Meeting, Cairo, Egypt.

Pincemail, J., Siquet, J., Chapelle, J.-P., Cheramy-Bien, J.-P., Paulissen, G., Chantillon, A.-M., Christiaens, G., Gielen, J., Limet, R., & Defraigne, J.-O. (2000). Evaluation des concentrations plasmatiques en anti-oxydants, anticorps contre les LDL oxydees et homocysteine dans un echantillon de la population liegeoise. Annales de Biologie Clinique, 58 (2, Mar-Apr), 177-85.
Peer Reviewed verified by ORBi

Dubois, E., NYS, M., LEDOUX, D., Canivet, J.-L., Chapelle, J.-P., & Damas, P. (January 2000). Intérêt de la procalcitonine dans le diagnostic des broncho-pneumonies liées au respirateur. Reanimation Urgences, 9 (supplément 2), 179S (SP299.
Peer reviewed

Chapelle, J.-P., Biessaux, Y., Legrand, V., & Gielen, J. (2000). Prognostic significance of increased baseline plasma troponin I levels in PTCA patients. Heart, 83 (suppl. II), 24.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Aldenhoff, M.-C., Pierard, L., & Gielen, J. (2000). Comparison of the stratus CS and Axsym analysers for determination of cardiac troponin I in plasma. Acta Clinica Belgica. Supplementum, (suppl.1), 14.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (02 December 1999). Changements des lots de réactifs et des calibrateurs et leurs effets sur le contôle de qualité interne [Paper presentation]. Symposium : 10 ans d'évaluation externe de la qualité en Belgique (1989-1999), Anvers, Belgium.

Elst, K. M. V., Chapelle, J.-P., Boland, P., Demolder, J., & Gouro, F. K. (December 1999). Analytic and clinical evaluation of the Abbott AxSYM cardiac troponin I assay. American Journal of Clinical Pathology, 122 (6), 745-752. doi:10.1093/ajcp/112.6.745
Peer Reviewed verified by ORBi

Biessaux, Y., Martinez, C., Chapelle, J.-P., & Legrand, V. (01 December 1999). Inflammatory response to coronary angioplasty: determinants and clinical applications [Poster presentation]. 7th Joint Meeting of the Belgian and Dutch Working Groups on Invasive Cardiology, Bruxelles, Belgium.

Gillery, P., Bordas-Fonfrère, M., Chapelle, J.-P., Hue, G., & Périer, C. (November 1999). Hémoglobine glyquée décentralisée [Poster presentation]. 13ème Journées Nationales de la Société Française de Biologie clinique, Lille, France.

Chapelle, J.-P. (11 October 1999). Troponin I: new methodological developments [Paper presentation]. meeting of Werkgroep Biologen Antwerpen, UIA, Anvers, Belgium.

Chapelle, J.-P. (October 1999). Dosage de la troponine I cardiaque sur l'analyseur stratus cs: expérience en laboratoire hospitalier [Paper presentation]. Colloque "Actualités en cardiologie: de la prévention à l'Urgences", Liège, Belgium.

Chapelle, J.-P., & Legrand, V. (October 1999). Marqueurs cardiaques : CK-MB ou troponines? [Paper presentation]. 16ème Colloque en Immunologie et Biologie spécialisée, Liège, Belgium.

Gillery, P., Bordas-Fonfrède, M., Chapelle, J.-P., Drouin, P., Hue, G., Levy-Marchal, C., Périer, C., Sélam, J. L., Slama, G., Thivolet, C., & Vialettes, B. (September 1999). HBA1c: clinical and biological agreement for standardization of assay methode. Report by the expert of ALFEDIAM (Association de Langue française pour l'étude du diabète et des maladies métaboliques) and SFBC (Société française de Biologie clinique). Diabète et Métabolisme, 25 (3), 283-7.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Lutteri, L., Legrand, V., & Gielen, J. (June 1999). Determination of total homocysteine in plasma by automated fluorescence polarization immunoassay [Poster presentation]. 17th International and 13th European Congress of Clinical Chemistry and Laboratory Medicine, Firenze, Italy.

Lutteri, L., Chapelle, J.-P., & Gielen, J.-L. (June 1999). Homocysteine et risque cardio-vasculaire. Revue Médicale de Liège, 54 (6), 541-7.
Peer reviewed

Chapelle, J.-P. (20 May 1999). Evaluation multicentrique de l'analyseur urinaire super aution ex [Paper presentation]. Colloque : automation et standardisation dans le domaines des analyses urinaires: biochimie et sédiment, Luxembourg.

Chapelle, J.-P., Geenen, V., Malaise, M., Franchimont, N., Legrand, V., & Damas, P. (13 March 1999). Cytokines et nouveaux marqueurs inflammatoires [Paper presentation]. Séance de Formation continue du Département de Biologie clinique, CHU Liège, Liège, Belgium.

Pelsers, M. M., Chapelle, J.-P., Knapen, M., Vermeer, C., Muijtjens, A. M., Hermens, W. T., & Glatz, J. F. (March 1999). Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clinical Chemistry, 45 (3), 441-3.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (February 1999). Comparison of troponin I and troponin T changes after PTCA [Paper presentation]. 7th Bergmeyer Conference on "Markers for cardiac Damage - current status and future trends", Tutzing, Germany.

Chapelle, J.-P. (January 1999). Cardiac Troponin I and Troponin T: Recent Players in the Field of Myocardial Markers. Clinical Chemistry and Laboratory Medicine, 37 (1), 11-20. doi:10.1515/CCLM.1999.002
Peer Reviewed verified by ORBi

Chapelle, J.-P., Lutteri, L., & Gielen, J. (1999). Evaluation of the homocysteine assay on the Abbott IMx. Clinical Chemistry, 45 (6), 134.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Gielen, J., Legrand, V., & Lutteri, L. (1999). Determination of total homocysteine in plasma by automated fluorescence polarization immunoassay. Clinical Chemistry and Laboratory Medicine, 37 (suppl), 373.
Peer Reviewed verified by ORBi

Biessaux, Y., Martinez, C., Chapelle, J.-P., & Legrand, V. (1999). Inflammatory response to coronary angioplasty: determinants and clinical implications. Acta Cardiologica, 54, 58.
Peer Reviewed verified by ORBi

Lutteri, L., Chapelle, J.-P., & Gielen, J. (1999). An association demonstrated between homocysteine, CRP and troponin levels in PTCA patients. Acta Clinica Belgica. Supplementum, (suppl.1), 15.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (05 December 1998). Evaluation biologique du risque cardio-vasculaire: choix des paramètres et assurance qualité [Paper presentation]. Réunion du Belgian Lipid club: recommandations pour le diagnostic et le traitement des dyslipémies, Sart Tilman, Liège, Belgium.

Galimany, R., Arambarri, M., Biosca, Ceriotti, F., Chapelle, J.-P., Lopez, R., Souverijn, J. H., Spagnuolo, G., Scopacasa, F., & Almirall, L. (December 1998). European multicentre evaluation of the Super Aution SA-4220 urinalysis analyser. Clinical Chemistry and Laboratory Medicine, 36 (12), 947-58. doi:10.1515/CCLM.1998.164
Peer Reviewed verified by ORBi

Chapelle, J.-P. (17 October 1998). Applications cliniques du soage de la troponine cardiaque: comparaison avec les marqueurs myocardiques classiques [Paper presentation]. 22nd National Symposium of the Belgian Sociéty of Clinical Biology, Leuven, Belgium.

Chapelle, J.-P. (10 October 1998). Les nouveaux marqueurs de l'infarctus du myocarde [Paper presentation]. Forum Médico-chirurgical de la Basse-Sambre: actualités en Biologie, Auvelais, Belgium.

Chapelle, J.-P. (October 1998). La troponine, nouveau marqueur de l'infarctus du myocarde. Revue Médicale de Liège, 53 (10), 619-24.
Peer reviewed

Chapelle, J.-P., Boland, P., Marechal, P., & Legrand, V. (May 1998). Evaluation of a new automated immunoassay for measuring cardiac troponin I in serum [Poster presentation]. VII International Congress on Automation and New Technology in Clinical Laboratory, Santiago de Compostella, Spain.

Chapelle, J.-P. (02 April 1998). La standardisation du dosage de l'hémoglobine glyquée: perspectives à court-terme [Paper presentation]. Réunion de la Société Luxembourgeoise de Biologie Clinique, Luxembourg.

Chapelle, J.-P., & Ferir, A. M. (26 March 1998). Incidence de la qualité analytique sur la variabilité des résultats de biologie clinique [Paper presentation]. Réunion scientifique du Département de Biologie clinique CHU Sart Tilman, Sart Tilman, Liège, Belgium.

De Roover, A., Dupont, G., Chapelle, J.-P., Krafft, M. P., Kerzmann, A., Meurisse, M., Lamy, M., Detry, O., Honore, P., Defraigne, J.-O., Jacquet, N., & D'Silva, M. (07 March 1998). Normothermic preservation of rabbit hearts using a new perfluorocarbon emulsion [Poster presentation]. Annual Meeting of the Belgian Transplantation Society, Brussels, Belgium.

Marechal, P., Legrand, V., Chapelle, J.-P., & Kulbertus, H. (1998). The clinical signification of troponin T, troponin I, CK and CK-MB after coronary angioplsaty. Acta Cardiologica, 53, 319.
Peer Reviewed verified by ORBi

Gillery, P., Bordas-Fonfrède, M., Chapelle, J.-P., Hue, G., & Périer, C. (1998). Hémoglobine glyquée : le temps de la standardisation est venu. Annales de Biologie Clinique, 56 (3), 249-51.
Peer Reviewed verified by ORBi

Gougnard, T., Chapelle, J.-P., Charlier, C., Plomteux, G., & Gielen, J. (18 October 1997). Discrepancy in hemoglobin A1c results obtained by HPLC and CE: influence of carbamyl HB [Poster presentation]. Symposium National de la Société Belge de Biologie Clinique, Louvain-La-Neuve, Belgium.

Chapelle, J.-P. (May 1997). La troponine, nouveau marqueur de l'infarctus du myocarde [Paper presentation]. Journées d'enseignement post-universitaire de l'AMLg, CHU Liège, Sart Tilman, Liège, Belgium.

Chapelle, J.-P. (13 March 1997). Les marqueurs myocardiques.

Chapelle, J.-P. (03 February 1997). Determination of CK-MB mass in clinical practice [Paper presentation]. Meeting of the Committee "Standardization of Immunoassays-Main Focus on cardiac Markers, Frankfurt, Germany.

Chapelle, J.-P. (06 December 1996). L'accès du pharmacien à le spécialisation en Biologie clinique [Paper presentation]. Journée d'information sur les carrières pharmaceutiques, Colonster, Liège, Belgium.

Chapelle, J.-P. (28 November 1996). Diagnostic d'infarctus du myocarde au stade aigu: aspects biochimiques.

Chapelle, J.-P., Jamar, M., & El Allaf, D. (19 October 1996). Influence of thrombolytic agents in serum levels of myocardial markers after acute myocardial infarction [Poster presentation]. 20th Symposium of the Belgian Society of Clinical Biology, Brugge, Belgium.

Chapelle, J.-P. (09 July 1996). Clinical interest of myoglobin and other non structural protein markers for the early diagnosis of myocardial infarction [Paper presentation]. XVI International Congress of Clinical Chemistry, London, United Kingdom.

Chapelle, J.-P. (13 June 1996). Actualités sur les marqueurs de l'infarctus du myocarde: choix, méthodes de mesure, interprétation [Paper presentation]. Séance d'Enseignement post-Universitaire, Strasbourg, France.

Chapelle, J.-P. (12 June 1996). Les nouveaux marqueurs myocardiques - impact sur la prise en charge du patient coronarien.

Chapelle, J.-P. (11 May 1996). Apport des nouveaux marqueurs biologiques au diagnostic et au suivi de l'infarctus du myocarde [Paper presentation]. 2ème Journée de Biologie clinique, Bruxelles, Belgium.

Chapelle, J.-P., & Férir, A. M. (21 March 1996). L'apoprotéine E et ses implications.

Chapelle, J.-P. (06 February 1996). Biochemical investigation of myocardial infarction [Paper presentation]. Meeting of the Department of Clinical Biology, Leuven, Belgium.

Chapelle, J.-P., Pierard, L., & El Allaf, D. (February 1996). Early assessment of coronary reperfusion after fibrinolysis by measuring cTnI, CK-MB and myoglobin in serum [Paper presentation]. Colloquium: Ischemic myocardial damage-early detection: Biochemical markers, Nice, France.

Chapelle, J.-P., El Allaf, M., Faymonville, M.-E., Albert, A., Larbuisson, R., Limet, R., & Lamy, M. (November 1995). Fast determination of troponin I using the stratus II analyser; application to patient follow-up after coronary bypass surgery [Poster presentation]. VI International Congress in Automation and new Technology in Clinical Laboratory, Barcelona, Spain.

Chapelle, J.-P., Spronck, T., Ferir, A. M., & Gielen, J. (November 1995). Performance characteristics of the CK-MB and myoglobin assays on the opus magnum system [Poster presentation]. IV International Congress in Automation and New Technology in Clinical Laboratory, Bercelona, Spain.

Chapelle, J.-P. (19 October 1995). L'apport des marqueurs biologiques dans le diagnostic et le suivi thérapeutique de l'infarctus du myocarde [Paper presentation]. Colloque : "Les marqueurs biologiques de l'infarctus", Gosselies, Belgium.

Chapelle, J.-P., Faymonville, M.-E., Larbuisson, R., Gielen, J., Limet, R., & Lamy, M. (14 October 1995). Comparison of serum CK-MB and troponin concentrations after coronary bypass surgery [Paper presentation]. 19ème Symposium de la Société Belge de Biologie Clinique, Sart Tilman, Liège, Belgium.

Chapelle, J.-P., Spronck, T., & Ferir, A. M. (July 1995). Analytical and clinical evaluation of automated immunoassays for serum CK-MB and myoglobin assays on ths opus magnum system [Poster presentation]. 47th Annual Meeting of the American Association of Clinical Chemistry, Anaheim, United States.

Chapelle, J.-P., Duvivier, J., & Gielen, J. (July 1995). Prognostic markers in malignant diseases [Paper presentation]. 11th IFCC European Congress of Clinical Chemistry, Tampere, Finland.

Chapelle, J.-P. (15 June 1995). Application clinique du dosage des sous-unités I et T de la troponine cardiaque [Paper presentation]. Colloque : "New developments in Clinical Chemistry", Bruxelles, Belgium.

Chapelle, J.-P., El Allaf, M., Faymonville, M.-E., Albert, A., Larbuisson, R., Limet, R., & Lamy, M. (May 1995). Evolution of serum cardiac troponin-I and CK-MB during and after coronary bypass surgery [Poster presentation]. 3rd International Congress on Heart failure - Mechanisms and Management, Geneva, Switzerland.

Chapelle, J.-P., & Saintouil, J. P. (April 1995). Troponin I: a new concept and new assay apllied to cardiovascular damage [Paper presentation]. 2nd Scientific Meeting of the European Ligand Assay Society, Brussels, Belgium.

Chapelle, J.-P., Spronck, T., & Ferir, A.-M. (1995). Analytical and clinical evaluation of automated immunoassays for serum CK-MB and myoglobin using the OPUS MAGNUM analyser. Clinical Chemistry, 41, 72.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Duvivier, J., & Gielen, J. (1995). Prognostic markers in malignant diseases. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum, 55, 223.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Lemache, K., el Allaf, M., El Allaf, D., & Pierard, L. (October 1994). Fast determination of myoglobin in serum using a new radial partition immunoassay. Clinical Biochemistry, 27 (5), 423-8. doi:10.1016/0009-9120(94)00046-8
Peer Reviewed verified by ORBi

Chapelle, J.-P., & El Allaf, D. (September 1994). Comparison of cardiac troponin I, total CK, CK-MB and myoglobin concentrations in plasma after radiofrequency catheter ablation [Paper presentation]. Colloquium: "The new cardiac marker: Troponin I. Results of clinical trials". XIIth World Congress of cardiology, Berlin, Germany.

Chapelle, J.-P. (September 1994). Usefulness of serum CK-MB determinations for assessing coronary artery reperfusion following thrombolytic therapy [Paper presentation]. 4th International Symposium on Guanidino Compounds in Biology and Medicine, Montreal, Canada.

Chapelle, J.-P. (June 1994). Early assessment of myocardial necrosis by means of serum troponin T measurements [Paper presentation]. Colloquium: "Marker-Rund um das Herz" und 1. Europaïches Cardiac Marker Experten-Treffen, Deutsches Herzzentrum München, Univ. München, Munich, Germany.

Chapelle, J.-P. (26 May 1994). Diagnostic biologique de l'infarctus du myocarde [Paper presentation]. Colloque : "Nouveaux marqueurs de l'infarctus du myocarde", Bruxelles, Belgium.

Chapelle, J.-P. (30 March 1994). Les nouveaux marqueurs cardiaques [Paper presentation]. Cooloque : "La place de la biologie dans le diagnostic et le suivi de l'infarctus du myocarde, Brugge, Belgium.

Chapelle, J.-P. (24 February 1994). Le point sur les marqueurs biologiques dans les affections cardiauqes [Paper presentation]. Séminaire de Biologie clinique, Hôpital Ambroise Paré, Mons, Belgium.

Devleeschouwer, N., Libeer, J. C., Chapelle, J.-P., Struway, C. L., Gyssels, C., L'Hoir, A., & Albert, A. (1994). Factors influencing between-laboratory variability of C-reactive protein results as evidenced by the Belgian External Quality Assessement (EQA) Scheme. Scandinavian Journal of Clinical and Laboratory Investigation, 54 (6), 435-40. doi:10.3109/00365519409085467
Peer Reviewed verified by ORBi

Chapelle, J.-P., Hing, M., Pierard, L., Gielen, J., & Kulbertus, H. (November 1993). Changes in the tissue-specific ck-MB2 concentrations in serum after myocardial infarction: comparison with total CK-MB [Poster presentation]. XVth International Congress of Clinical Chemistry, Melbourne, Australia.

Chapelle, J.-P. (08 October 1993). Measurement of myoglobin in myocardial necrosis and reperfusion [Paper presentation]. Colloquium : "New biochemical markers of myocardial necrosis and coronary reperfusion", Barcelona, Spain.

Chapelle, J.-P. (May 1993). Immunoassays for CK-MB and myoglobin: application to the early diagnosis and follow-up of myocardial infarction [Paper presentation]. Symposium "Immunoassays in the clinical laboratory", Brussels, Belgium.

Chapelle, J.-P. (May 1993). Clinical significance of myoglobin [Paper presentation]. 5th International Symposium on New Biochemical markers in Cardio vascular disease and flow cytometry in laboratory medicine, Brugge, Belgium.

Evrard, B., Chapelle, J.-P., & Gielen, J. (May 1993). Evaluations of an immunonephelometric assay for serum lipoprotein (a) [Poster presentation]. 5th International Symposium on New Biochemical merkers in Cardiovascular disease and flow cytometry in laboratory medicine, Brugge, Belgium.

Chapelle, J.-P. (13 April 1993). Les indicateurs biochimiques de reperfusion myocardique après thérapeutique fibrinolytique.

Dexleeschouwer, N., Libeer, J. C., Chapelle, J.-P., Struvay, C., Gyssels, C., & L'Hoir, A. (April 1993). C-reactive protein (CRP) : study of the between-laboratory performance of the belgian external quality assessment (EQA) of clinical biology [Poster presentation]. 10th IFCC European Congress of Clinical Chemistry, Nice, France.

Chapelle, J.-P. (April 1993). Early diagnosis of myocardial infarction by measuring the tissue isoform of CK-MB in serum [Paper presentation]. 10th IFCC European Congress of Clinical Chemistry, Nice, France.

Hing, M., & Chapelle, J.-P. (1993). Determination of tissue-specific CK-MB2 in serum after myocardial damage. European Journal of Clinical Chemistry and Clinical Biochemistry: Journal of the Forum of European Clinical Chemistry Societies, 31, 4.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (1993). Early diagnosis of myocardial infarction by measuring the tissue isoform of CK-MB in serum. Annales de Biologie Clinique, 51, 350.
Peer Reviewed verified by ORBi

Devleeschouwer, N., Libeer, J. C., Chapelle, J.-P., Struvay, C., Gyssels, C., & L'Hoir, A. (1993). C-reactive protein (CRP): study of the between-laboratory performance of the belgian external quality assessment (EQA) of clinical biology. Annales de Biologie Clinique, 51, 524.
Peer Reviewed verified by ORBi

Chapelle, J.-P., & El Allaf, D. (1993). Early diagnosis of myocardial infarction using a new automated immunoassay for serum myoglobin. European Heart Journal Supplements: Journal of the European Society of Cardiology, 14 (Abs. suppl.), 32.
Peer Reviewed verified by ORBi

Chapelle, J.-P., El Allaf, D., & El Allaf, M. (September 1992). Comparison of the Diagnostic performances of early myoglobin and CK-MB measurements in patients suspected of myocardial infarction [Paper presentation]. 8ème Colloque International "Biologie Prospective", Metz, France.

Lammers, M., Chapelle, J.-P., Delanghe, J., Neumeier, D., Puschendorf, B., Roxin, L. E., & Zoppi, F. (August 1992). Multicentric evaluation of a turbidimetric myoglobin immunoassay [Poster presentation]. XXIII Nordiske Kongres i Klinisk Kemi, Reykjavik, Iceland.

Chapelle, J.-P., El Allaf, D., & El Allaf, M. (1992). Comparison of the diagnostic performances of early myoglobin and CK-MB measurements in patients suspected of myocardial infarction. Annales de Biologie Clinique, 50, 542.
Peer Reviewed verified by ORBi

Lammers, M., Chapelle, J.-P., Delanghe, J., Neumeier, D., Puschendorf, B., Roxin, L. E., & Zoppi, F. (1992). Multicentric evaluation of turbimetric myoglobin immunoassay. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum, 52 (221), 109.
Peer Reviewed verified by ORBi

Hoffer, E., Pierard, L., Chapelle, J.-P., & Kulbertus, H. (1992). Is there a relation between myocardial salvage and the release patterns of myoglobin and creatine kinase-MB in acute myocardial infarction submitted to thrombolysic? Acta Cardiologica, 250.
Peer Reviewed verified by ORBi

Hoffer, E., Pierard, L., Chapelle, J.-P., & Kulbertus, H. (October 1991). is there a relation between myocardial salvage and the release patterns of myoglobin and creatine kinase-MB in acute myocardial infarction submitted to thrombolysis? [Poster presentation]. Réunion de la Société Belge de Cardiologie, Bruxelles, Belgium.

Chapelle, J.-P. (30 September 1991). Transformation post-synthétique des marqueurs tissulaires: apllication au suivi du patient atteint d'infarctus du myocarde.

Chapelle, J.-P. (September 1991). Determination of creatine kinase isoforms in serum: clinical interest in patients with acute myocardial infarction [Paper presentation]. Third International Symposium on Guanidino Compounds in Biology and Medicine, Antwerp, Belgium.

Chapelle, J.-P., El Allaf, D., & El Allaf, M. (September 1991). Comparison of the performances of myoglobin and CK-MB for the early diagnosis of myocardial infarction [Poster presentation]. IXth European Congress of Clinical Chemistry, Krakow, Poland.

Albert, A., Chapelle, J.-P., Ongaro, C., Ney, J.-M., Delens, G., Gielen, J., Plomteux, G., Bouvier, J. L., & Foray, G. (May 1991). LILAS, an integrated laboratory information system [Poster presentation]. 8th International Conference on computing in clinical laboratories, Toulouse, France.

Chapelle, J.-P. (25 April 1991). Intérêt du dosage de la myoglobine sérique dans le diagnostic précoce de l'infarctus du myocarde.

Chapelle, J.-P. (25 March 1991). Myoglobine: méthodes analytiques et interprétation clinique.

Chapelle, J.-P. (12 February 1991). chronologie de libération des marqueurs tissulaires dans l'ischémie myocardique.

Lammers, M., Dati, F., Kapmeyer, W. H., Chapelle, J.-P., Delanghe, J., Neumeier, D., Puschendorf, B., Roxin, L. E., & Zoppi, F. (1991). Evaluation of a rapid turbidimetric myoglobin immunoassay. Clinical Chemistry, 37, 1062.
Peer Reviewed verified by ORBi

Chapelle, J.-P., El Allaf, D., & El Allaf, M. (1991). Serum levels of myosin heavy chains and other tissue markers compared in patients with myocardial infarction and angina pectoris [Poster presentation]. 43rd National Meeting of the American Association for Clinical Chemistry, Washingtion DC, United States.

Delanghe, J., Chapelle, J.-P., el Allaf, M., & De Buyzere, M. (1991). Quantitative turbidimetric assay for determining myoglobin evaluated. Annals of Clinical Biochemistry, 28 ( Pt 5), 474-9. doi:10.1177/000456329102800509
Peer Reviewed verified by ORBi

Chapelle, J.-P., El Allaf, D., & El Allaf, M. (1991). Serum levels of myosin heavy chains and other tissue markers compared in patients with myocardial infarction and angina pectoris. Clinical Chemistry, 37, 1062-1063.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (08 November 1990). Etude de l'efficacité de la myoglobine et de la CK-MB pour le diagnostic et le suivi de l'infarctus du myocarde [Paper presentation]. Colloque scientifique de l'Hôpital civil de Verviers, Verviers, Belgium.

Chapelle, J.-P., & El Allaf, D. (November 1990). Changes in serum total creatine kinase (CK), CK-MB and myoglobin levels after intracardiac shocks for atrial defibrillation [Paper presentation]. International Congress of Clinical Enzymology, Roma, Italy.

Chapelle, J.-P. (25 October 1990). Comparaison de deux marqueurs précoces de l'infarctus du myocarde : la CK-MB et la myoglobine [Paper presentation]. Réunion scientifique des Médecins généralistes, Fleurus, Belgium.

Chapelle, J.-P., & El Allaf, M. (October 1990). Analytical and clinical performances of a new automated immunoassay for measuring CK-MB in serum [Paper presentation]. 4th International Congress on Automation and New Technology in the Clinical Laboratory, Barcelone, Spain.

Ordonez, J., Chapelle, J.-P., Serra, J. R., Martinez, C., & Gonzalez, F. (October 1990). Basal and postexercise CK 2 concentrations in a group of well trained athletes evaluated by chemiluminescent assay [Poster presentation]. Automation and New Technology in the Clinical Laboratory, Barcelone, Spain.

Chapelle, J.-P. (29 September 1990). Intérêt des isoformes de la creatine kinase dans le diagnostic de l'infarctus du myocarde [Paper presentation]. 14ème Symposium de la Société Belge de Biologie Clinique, Gent, Belgium.

Chapelle, J.-P. (22 September 1990). Intérêt du dosage de la myoglobine dans l'infarctus du myocarde [Paper presentation]. 11ème Journée Nationale de Biologie clinique, Luxembourg, Luxembourg.

Delanghe, J. R., Chapelle, J.-P., & Vanderschueren, S. C. (September 1990). Quantitative nephelometric assay for determining myoglobin evaluated. Clinical Chemistry, 36 (9), 1675-8. doi:10.1093/clinchem/36.9.1675
Peer Reviewed verified by ORBi

Chapelle, J.-P. (23 July 1990). Myoglobin in the early detection and therapy follow-up of acute myocardial infarction : comparison with heart enzymes [Paper presentation]. Symposium : Laboratory in cardiac disease: from risk assessment to therapy monitoring, San Francisco, United States.

Chapelle, J.-P., El Allaf, M., Pierard, L., & Kulbertus, H. (July 1990). Usefulness of CRP determination after acute myocardial infarction [Poster presentation]. XIVth International Congress of Clinical Chemistry, San Francisco, United States.

Dati, F., Lammers, M., Kapmeyer, W. H., Bayer, P. M., Burlina, A., Chapelle, J.-P., & Delanghe, J. (July 1990). Clinical evaluation of a nephelometric myoglobin immunoassay [Poster presentation]. XiVth International Congress of Clinical Chemistry, San Francisco, United States.

Chapelle, J.-P. (27 June 1990). Myoglobine et infarctus du myocarde [Paper presentation]. Réunion scientifique de l'Hôpital de Jolimont, Haine-St-Paul, Belgium.

Chapelle, J.-P., & El Allaf, M. (June 1990). Determination of myoglobin in serum by kinetic turbidimetry, using the turbitimesystem. Clinical Chemistry, 36 (6), 1193.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (31 May 1990). Analytical evaluation of the latex-enchanced myoglobin immunoassay on Behring nephelometer and turbitimer [Paper presentation]. Behring Immunoassay Systems 2nd Users Conference, Leuven, Belgium.

Chapelle, J.-P., El Allaf, M., Pierard, L., & Kulbertus, H. (May 1990). Serum APO A-1 and APO-B levels negatively correlate to enzymatic infarct size after myocardial infarction [Poster presentation]. 55th Annual Meeting of the European Atherosclerosis Society, Brugge, Belgium.

Chapelle, J.-P., & El Allaf, M. (April 1990). Radial partition immunoassay applied to automated quantification of CK-MB in serum [Paper presentation]. International Symposium on Biotechnology of plasma proteins, Florence, Italy.

Dati, F., Lammers, M., Kapmeyer, W. H., Bayer, P. M., Burlina, A., Chapelle, J.-P., & Delanghe, J. (1990). Clinical evaluation of a nephelometric myoglobin immunoassay. Clinical Chemistry, 36, 1192.
Peer Reviewed verified by ORBi

Chapelle, J.-P., & El Allaf, M. (January 1990). Automated quantification of creatinine kinase MB isoenzyme in serum by radial partition immunoassay, with use of the Stratus analyzer. Clinical Chemistry, 36 (1), 99-101. doi:10.1093/clinchem/36.1.99
Peer Reviewed verified by ORBi

Chapelle, J.-P., El Allaf, M., Pierard, L., & Kulbertus, H. (1990). Usefulness of CRP determination after acute myocardial infarction. Clinical Chemistry, 36, 992.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (02 December 1989). Les marqueurs tissulaires dans l'infarctus du myocarde [Paper presentation]. Réunion de la Société Belge de Chimie Clinique, Sart Tilman, Belgium.

Chapelle, J.-P., El Allaf, M., Pierard, L., & Kulbertus, H. (September 1989). Correlation between c-reactive protein (CRP) levels and the importance of enzyme release after myocardial infarction [Poster presentation]. XIth International Congress of the European Society of Cardiology, Nice, France.

El Allaf, M., Chapelle, J.-P., El Allaf, D., & Kulbertus, H. (September 1989). Significance of serum creatine kinase isoforms for assessing myocardial infarction [Poster presentation]. XIth International Congress of the European Society of Cardiology, Nice, France.

Chapelle, J.-P., & El Allaf, M. (August 1989). Automated quantification of creatine kinase-MB in serum by radial partition immunoassay [Paper presentation]. Colloque : Stratus CK-MB : A fully Automated fluorescence enzyme-immunoassay, Zurich, Switzerland.

Chapelle, J.-P. (27 June 1989). Early detection and therapy follow-up of acute myocardial infarction by myoglobin measurement [Paper presentation]. Colloque : New Aspects in Laboratory Diagnostics of Heart Diseases, Milan, Italy.

Chapelle, J.-P., & El Allaf, M. (June 1989). Automated quantification of creatine kinase (CK)-MB by a new fluorometric enzyme immunoassay [Paper presentation]. 8th European Congress of Clinical Chemistry, Milan, Italy.

Chapelle, J.-P. (June 1989). Evolution of serum CK-MB isoforms after acute myocardial-infarction. Clinical Chemistry, 35 (6), 1120.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Albert, A., & Heusghem, C. (1989). Comparison of the long-term predictive efficiency of two serum glycoproteins, alpha 1-acid glycoprotein and haptoglobin, in patients with myocardial infarction [Poster presentation]. XII Internatioanl Congress of Clinical Chemistry, Rio de Janeiro, Brazil.

Albert, A., Chapelle, J.-P., & Heusghem, C. (1989). Daily Prediction of the patients outcome from cumulative laboratory data after an acute myocardial infarction [Poster presentation]. XII International Congress of Clinical Chemistry, Rio de Janeiro, Brazil.

El Allaf, M., Chapelle, J.-P., El Allaf, D., & Kulbertus, H. (1989). Significance of serum creatine kinase isoforms for assessing myocardial infarction. European Heart Journal Supplements: Journal of the European Society of Cardiology, 10 (suppl.1), 224.
Peer Reviewed verified by ORBi

El Allaf, M., & Chapelle, J.-P. (1989). Changes in isoform patterns and stability of CK-MB during storage. Clinical Chemistry, 35, 1120-1121.
Peer Reviewed verified by ORBi

Pierard, L., Dubois, C., Albert, A., Chapelle, J.-P., Carlier, J., & Kulbertus, H. (1989). Prognostic significance of a low peak serum creatine kinase level in acute myocardial infarction. American Journal of Cardiology, 63 (12), 792-6. doi:10.1016/0002-9149(89)90044-1
Peer Reviewed verified by ORBi

Chapelle, J.-P., El Allaf, M., Pierard, L., & Kulbertus, H. (1989). Correlation between c-reactive protein (CRP) levels and the importance of enzyme release after myocardial infarction. European Heart Journal Supplements: Journal of the European Society of Cardiology, 10 (suppl.1), 262.
Peer Reviewed verified by ORBi

Pierard, L., Albert, A., Chapelle, J.-P., Carlier, J., & Kulbertus, H. (1989). Relative prognostic value of clinical, biochemical, echocardiographic and haemodynamic variables in predicting in-hospital and one-year cardiac mortality after acute myocardial infarction. European Heart Journal, 10 (1), 24-31. doi:10.1093/oxfordjournals.eurheartj.a059377
Peer Reviewed verified by ORBi

Chapelle, J.-P., El Allaf, M., Ney, J.-M., & Delens, G. (October 1988). Evaluation d'un lecteur automatique de tigettes urinaires, le Rapimat II/T [Poster presentation]. 7ème Colloque International de Pont-à-Mousson, Pont-à-Mousson, France.

Chapelle, J.-P., El Allaf, M., Albert, A., & Kulbertus, H. (September 1988). Serum creatine kinase isoenzymes and isoenzymes and isoforms as indicators of coronary reperfusion in acute myocardial infarction [Paper presentation]. 7th International Congress on Clinical Enzymology, Osaka, Japan.

Chapelle, J.-P. (15 June 1988). Intérêt du dosage des isoenzymes de la CK et de la LDH par électrophorèse [Paper presentation]. Colloque : Rapid Electrophoresis System for Isoenzyme Separation in Clinical Chemistry, Bruxelles, Belgium.

Poncin, J. E., Delhase, M., & Chapelle, J.-P. (May 1988). Incidence of apolipoprotein genotypes on the prevalence and size of myocardial infarction [Poster presentation]. 18th International Symposium of the Belgian Society for Clinical Chemistry, Brugge, Belgium.

Chapelle, J.-P., Delwaide, P., Gielen, J., & Poncin, J. (25 February 1988). Atheromasie et lipides [Paper presentation]. Informations scientifiques des Biologistes, Liège, Belgium.

Chapelle, J.-P., El Allaf, M., Faymonville, M.-E., Albert, A., Larbuisson, R., Limet, R., & Lamy, M. (1988). Evolution of serum creatine kinase (CK)-MB isoforms during and after coronary surgery. European Heart Journal Supplements: Journal of the European Society of Cardiology, 9 (suppl.1), 244.
Peer Reviewed verified by ORBi

Chapelle, J.-P., El Allaf, M., Ney, J.-M., & Delens, G. (1988). Evaluation d'un lecteur automatique de tigettes urinaires, le RapimatII/T. Annales de Biologie Clinique, 46 (7), 619.
Peer Reviewed verified by ORBi

Chapelle, J.-P., El Allaf, M., Faymonville, M.-E., Albert, A., Larbuisson, R., Limet, R., & Lamy, M. (1988). Evolution of serum creatine kinase (CK)-MB isoforms during and after coronary surgery [Poster presentation]. Xth Congress of the European Society of Cardiology, Vienne, Austria.

Delandsheere, C. M., Raets, D., Pierard, L., Berthe, C., Legrand, V., Crochelet, L., Chapelle, J.-P., Lemaire, C., Delfiore, G., Guillaume, M., Lamotte, D., Kulbertus, H., & Rigo, P. (October 1987). Thrombolysis in anterior myocardial-infarction-effect onregionnal viability studied with positron emission tomography. Circulation, 76 (4), 5.
Peer Reviewed verified by ORBi

Dubois, C., Pierard, L., Albert, A., Chapelle, J.-P., Heusghem, C., & Kulbertus, H. (05 September 1987). Short and long-term prognosis of small acute myocardial infarction: a natural history study [Poster presentation]. 5th Joint Meeting of the Working Groups of the European Society of Cardiology and Symposium on ten years balloon dilatation in cardiovascular disease, Santiago de Compostella, Spain.

Chapelle, J.-P., El Allaf, M., Pierard, L., & Kulbertus, H. (05 September 1987). Serum creatine kinase isoenzymes and isoforms as indictors of coronary reperfusion in acute myocardial infarction [Paper presentation]. 5th Joint Meeting of the Working Groups of the European Society of Cardiology and Symposium on ten years balloon dilation in cardiovascular disease, Santiago de Compostella, Spain.

Chapelle, J.-P., Smeets, J. P., El Allaf, M., Albert, A., Heusghem, C., & Kulbertus, H. (05 September 1987). Early prognostic index and late exercise test comapred in survivors from acute myocardial infarction [Poster presentation]. 5th Joint Meeting of the Working Groups of European Society of Cardiology and Symposium on ten years balloon dilation in cardiovascular disease, Santiago de Compostella, Spain.

Chapelle, J.-P. (September 1987). Biomedical risk analysis in patients with myocardial infarction [Paper presentation]. Week of Medicine : Deutsche Demokratische Republik/Königreich Belgien, Dresden, DDR.

de Landsheere, C., Raets, D., Pierard, L., Berthe, C., Legrand, V., Crochelet, L., Chapelle, J.-P., Del Fiore, C., Lemaire, C., Degueldre, C., Peters, J. P., Quaglia, L., Guillaume, M., Lamotte, D., Kulbertus, H., & Rigo, P. (September 1987). Viabilité myocardique après infarctus du myocarde traité par fibrinolyse: évaluation directe par tomographie à émission de positons combinant une étude régionale de la perfusion et de la captation glucidique [Poster presentation]. Congrès de Médecine Nucléaire, Liège, Belgium.

Chapelle, J.-P., Smeets, J. P., El Allaf, M., Albert, A., Heusghem, C., & Kulbertus, H. (June 1987). Validation of an early prognostic index by exercise test data in survivors from acute myocardial infarction [Paper presentation]. 6th International Meeting on Clinical Laboratory Organization and Management: "Laboratory data and patient care", Noordwijkerhout, Netherlands.

Chapelle, J.-P., El Allaf, M., El Allaf, D., & Albert, A. (May 1987). L'immunoenzymétrie améliore les performances diagnostiques du dosage de la CK-MB chez le patient atteint d'infarctus du myocarde [Poster presentation]. 6èmes Journées Nationales de la SFBC, Le Touquet, France.

Chapelle, J.-P., Smeets, J. P., El Allaf, M., Pierard, L., Heusghem, C., & Kulbertus, H. (April 1987). Relation entre index pronostique précoce et test d'effort à 3 mois chez le patient atteint d'infarctus myocardique aigu [Poster presentation]. 14ème Congrès de Cardiologie de Langue française, Bruxelles, Belgium.

Pierard, L., Dubois, C., Albert, A., Chapelle, J.-P., Smeets, J. P., Carlier, J., & Kulbertus, H. (April 1987). Pronostic des infarctus myocardiques de petite taille [Poster presentation]. 14ème Congrès de Cardiologie de langue française, Bruxelles, Belgium.

Chapelle, J.-P., Smeets, J. P., El Allaf, M., Albert, A., Heusghem, C., & Kulbertus, H. (1987). Early pronostic index and late exercise test compared in survivors from acute myocardial infarction. European Heart Journal Supplements: Journal of the European Society of Cardiology, 8 (suppl.2), 11.
Peer Reviewed verified by ORBi

Chapelle, J.-P., & El Allaf, M. (1987). A simplified enzyme immunassay for serum lipase determination. Annals of Clinical Biochemistry, 24 (2), 216-217.
Peer Reviewed verified by ORBi

Chapelle, J.-P., & El Allaf, M. (1987). A simplified enzyme immunoassay for serum lipase determination [Paper presentation]. XIII International Congress of Clinical Chemistry, VII European Congress of Clinical Chemistry, The Hague, Netherlands.

Dubois, C., Pierard, L., Albert, A., Chapelle, J.-P., Smeets, J. P., & Kulbertus, H. (1987). Short and long-term prognosis of small acute myocardial infarction : a natural history study. European Heart Journal Supplements: Journal of the European Society of Cardiology, 8 (suppl.2), 110.
Peer Reviewed verified by ORBi

El Allaf, M., Chapelle, J.-P., & Heusghem, C. (1987). Laboratory and clinical assessment of a new sensitive immuno-radiometric assay for thyrotrophin in serum. Annals of Clinical Biochemistry, (Suppl.2), 176.
Peer Reviewed verified by ORBi

El Allaf, M., Chapelle, J.-P., & Heusghem, C. (1987). Laboratory and Clinical assessment of a new sensitive immunoradiometric assay for thyrotrophin in serum [Poster presentation]. XIII International Congress of Clinical Chemistry, VII European Congress of Clinical Chemistry, The Hague, Netherlands.

Chapelle, J.-P., & El Allaf, M. (1987). Determination of the performance characteristics of enzyme immunoassays using the photon era automatic analyszer. Annals of Clinical Biochemistry, 24 (suppl. 2), 116.
Peer Reviewed verified by ORBi

Chapelle, J.-P., El Allaf, M., & Pierard, L. (1987). Serum creatine kinase isoenzymes ans isoforms as indicators of coronary reperfusion in acute myocardial infarction. European Heart Journal Supplements: Journal of the European Society of Cardiology, 8 (suppl.2), 150.
Peer Reviewed verified by ORBi

de landsheere, C. M., Raets, D., Pierard, L., Berthe, C., Legrand, V., Crochelet, L., Chapelle, J.-P., Lemaire, C., del Fiore, G., Guillaume, M., Lamotte, D., Kulbertus, H., & Rigo, P. (1987). Thrombolysis in anterior myocardial infarction: effect on regional viability studied with positon emission tomography. Circulation, 76 (suppl.IV), 5.
Peer Reviewed verified by ORBi

El Allaf, M., Chapelle, J.-P., & Heusghem, C. (May 1986). Thrombolytic therapy reduces the acute phase response after acute myocardial infarction [Poster presentation]. XXXIV Annual Colloquium: Protides of the Biological Fluids, Brussels, Belgium.

Chapelle, J.-P. (May 1986). Determination of creatine kinase subisoenzymes by isoelectric focusing : new perspectives for clinical enzymology [Paper presentation]. XXXIV Annual Colloquim : Protides of the Biological Fluids, Brussels, Belgium.

Chapelle, J.-P. (22 March 1986). Evolution des marqueurs sanguins de la nécrose myocardique en fonction des interventions précoces [Paper presentation]. Journée de Cardiologie : le traitement de l'infarctus du myocarde au stade aigu, Liège, Belgium.

el Allaf, M., Chapelle, J.-P., El Allaf, D., Adam, A., Faymonville, M.-E., Laurent, P., & Heusghem, C. (February 1986). Differentiating muscle damage from myocardial injury by meaans of the serum creatinine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio. Clinical Chemistry, 32 (2), 291-5.
Peer Reviewed verified by ORBi

El Allaf, M., Chapelle, J.-P., & Heusghem, C. (1986). The diagnostic efficiency of serum CK-MB measurements in the early phase of acute myocardial infarction: comparison of five different techniques [Poster presentation]. IIIrd African, Mediterranean and Near East Congress of Clinical Chemistry, Sevilla, Spain.

El Allaf, M., Chapelle, J.-P., & Heusghem, C. (1986). Evaluation of a new immunoassay analyzer: the photon "ERA" [Poster presentation]. IIIrd African, Mediterranean and Near East Congress of Clinical Chemistry, Sevilla, Spain.

Chapelle, J.-P., el Allaf, M., Larbuisson, R., Limet, R., Lamy, M., & Heusghem, C. (1986). The value of serum CK-MB and myoglobin measurements for assessing perioperative myocardial infarction after cardiac surgery. Scandinavian Journal of Clinical and Laboratory Investigation, 46 (6), 519-26. doi:10.3109/00365518609083707
Peer Reviewed verified by ORBi

El Allaf, D., Demey-Ponsart, E., Pirotte, J., Chapelle, J.-P., el Allaf, M., Carlier, J., & Van Cauwenberge, H. (1986). Role de l' alpha 1-glycoproteine acide plasmatique dans la fixation de l'aminopyrine. Archives Internationales de Physiologie et de Biochimie, 94 (5), 317-22. doi:10.3109/13813458609071431
Peer Reviewed verified by ORBi

Chapelle, J.-P., El Allaf, D., el Allaf, M., Heusghem, C., Carlier, J., & Kulbertus, H. (1986). Serum creatine kinase isoenzyme MB concentration after endomyocardial biopsy. Clinica Chimica Acta, 157 (1), 55-63. doi:10.1016/0009-8981(86)90317-7
Peer Reviewed verified by ORBi

Adam, A., Boulanger, J., Chapelle, J.-P., Ers, P., Reynaert, M., & Roeseler, J. (1986). The immunochemical determinations of serum lipase in acute pancreatitis: further results. Clinical Chemistry, 32 (10), 1987. doi:10.1093/clinchem/32.10.1987a
Peer Reviewed verified by ORBi

Chapelle, J.-P. (1986). Clinical interest of the serum subisoenzymes of creatine kinase (CK) MM and MB in patients with acute myocardial infarction [Paper presentation]. iiird African, Mediterranean and Near East Congress of Clinical Chemistry, Seville, Spain.

Chapelle, J.-P., El Allaf, M., & Heusghem, C. (1986). Assessing successful myocardium reperfusion after thrombolytic therapy in acute myocardial infarction patients by early measurement of the serum CK-MB isoenzyme and of the CK-MM isoforms [Poster presentation]. IIIrd African, Mediterranean and Near East Congress of Clinical Chemistry, Sevilla, Spain.

Chapelle, J.-P., El Allaf, M., El Allaf, D., & Albert, A. (December 1985). Avantage d'une nouvelle méthodes de dosage de la CK-MB dans le diagnostic précoce de l'infarctus du myocarde [Paper presentation]. 13ème Congrès de Cardiologie de Langue Française, Fort de France, Martinique.

Chapelle, J.-P., El Allaf, M., El Allaf, D., Carlier, J., & Heusghem, C. (December 1985). Contrôle de l'efficacité du traitement fibrinolytique par mesures répétées de la CK-MB sérique chez le patient atteint d'infarctus myocardique aigu [Poster presentation]. 13ème Congrès de Cardiologie de Langue française, Fort de France, Martinique.

Chapelle, J.-P., El Allaf, M., Larbuisson, R., Limet, R., Lamy, M., & Heusghem, C. (November 1985). Improved detection of perioperative myocardial infarction after cardiac surgery using CK-MB mass measurements [Paper presentation]. Joint Workshop "Coronary Artery Surgery for the Nineties", Salzburg, Austria.

Heusghem, C., Chapelle, J.-P., & Kulbertus, H. (29 October 1985). Contribution de la Chimie clinique au diagnostic et au pronostic et au pronostic de l'infarctus du myocarde [Poster presentation]. Séances des Académies de Médecine de France et de Belgique, Paris, France.

Chapelle, J.-P., El Allaf, M., & Heusghem, C. (October 1985). Evaluation of a new immunoenzymatic assay for CK-MB [Poster presentation]. 6ème Colloque Inetrnational "Biologie Prospective", Pont-à-Mousson, France.

Chapelle, J.-P. (October 1985). Clinical application of the heterogeneity of creatine kinase isoenzyme MM [Paper presentation]. 3rd International Symposium of the Belgian Society of Clinical Chemistry, Brugge, Belgium.

El Allaf, M., Chapelle, J.-P., El Allaf, D., & Heusghem, C. (October 1985). Comparison of CK-MB concentrations in heart and in skeletal muscles and in serum after myocardial infarction, burns and multiple trauma [Poster presentation]. 3rd International Symposium of the Belgian Society of Clinical Chemistry, Brugge, Belgium.

Adam, A., Chapelle, J.-P., & Albert, A. (September 1985). Acute phase proteins: current status and new developments [Poster presentation]. 6th European Congress of Clinical Chemistry, Jerusalem, Israel.

Chapelle, J.-P., El Allaf, M., & Heusghem, C. (September 1985). Serum CK-MB after myocardial infarction and coronary bypass surgery: superiority of mass concentration over determination of catalytic activity [Poster presentation]. 5th International Congress on Clinical Enzymology, Jerusalem, Israel.

Chapelle, J.-P., El Allaf, D., El Allaf, M., Carlier, J., & Kulbertus, H. (September 1985). Patterns of total CK, CK-MB and myoglobin release following endomyocardial biopsy [Poster presentation]. 5th International Congress on Clinical Enzymology, Jerusalem, Israel.

Albert, A., Chapelle, J.-P., El Allaf, D., Heusghem, C., & Kulbertus, H. (August 1985). Computerization and routine use of dynamic risk index for acute myocardial infarction patients [Paper presentation]. 5th International Meeting on Clinical Laboratory Organization and Management, Haifa, Israel.

Albert, A., Chapelle, J.-P., & Heusghem, C. (June 1985). Monitorage biochimique et prédiction journalière du risque chez les patients atteints d'infarctus du myocarde [Poster presentation]. 5èmes Journées Lilloises de Biologie clinique, Foire Internationale, Lille, France.

El Allaf, M., & Chapelle, J.-P. (13 May 1985). Analytical and clinical evaluation of the TANDEM-E CKMB assay [Paper presentation]. Hybritech Symposium, Sart Tilman, Liège, Belgium.

Chapelle, J.-P. (May 1985). Interst of creatine kinase MM isoforms for the assessment and monitoring of myocardial infarction [Paper presentation]. II. Leonor-Michaelis-Symposium "Multiple Formen von Enzymen", Weimar, DDR.

Chapelle, J.-P., & El Allaf, M. (16 March 1985). New perspectives in myocardial necrosis assessment [Paper presentation]. Colloquium "New perspectives in CK-MB parameter", Brussels, Belgium.

Chapelle, J.-P. (09 March 1985). Intérêt de la myoglobine plasmatique dans le diagnostic précoce de l'infarctus du myocarde [Paper presentation]. Journée scientifique de la Clinique de Visé, Visé, Belgium.

Chapelle, J.-P., El Allaf, M., & Heusghem, C. (1985). Evaluation of a new immunoenzymetric assay for CK-MB (tandem-E CKMB). Annales de Biologie Clinique, 43, 634.
Peer Reviewed verified by ORBi

Hans, P., Albert, A., Born, J. D., & Chapelle, J.-P. (1985). Derivation of a bioclinical prognostic index in severe head injury. Intensive Care Medicine, 11 (4), 186-91. doi:10.1007/BF00272401
Peer Reviewed verified by ORBi

Chapelle, J.-P., & Heusghem, C. (1985). Semi-quantitative estimation of serum myoglobin by a rapid latex agglutination method: an emergency screening test for acute myocardial infarction. Clinica Chimica Acta, 145 (2), 143-50. doi:10.1016/0009-8981(85)90281-5
Peer Reviewed verified by ORBi

Heusghem, C., Chapelle, J.-P., & Kulbertus, H. (1985). Contribution de la chimie clinique au diagnostic et au pronostic de l'infarctus du myocarde. Bulletin de l'Académie Nationale de Médecine, 169 (7), 1097-107.
Peer Reviewed verified by ORBi

Hans, P., Born, J. D., Kalangu, K., Chapelle, J.-P., & Albert, A. (1985). Studio della pressione endocranica nei traumatizzati cranici gravi. Correlazione tra la gravita del trauma ed il valore prognostico. Minerva Anestesiologica, 51 (7-8), 377-9.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (06 October 1984). Perspectives nouvelles pour l'évaluation de la myoglobine sérique dans le décours de l'infarctus du myocarde [Paper presentation]. Journée Nationale Luxembourgeoise de Biologie clinique, Walferdange, Luxembourg.

El Allaf, M., Chapelle, J.-P., & Heusghem, C. (02 May 1984). Critical evaluation of a new immunoenzymetric assay for the dertermination of serum CK-MB : TANDEM -E CKMB. Preliminary results [Paper presentation]. Monoclonal antibodies, today's opportunities and tomorrow's perspectives, Brussels, Belgium.

Hans, P., Born, J. D., Chapelle, J.-P., & Albert, A. (April 1984). Etude de la PIC chez les traumatisés craniens graves. Correlation avec la gravité du coma et valeur pronostique [Poster presentation]. La Riunione Italo-Francese di Neuroanetesia e Rianimazione, Turin, Italy.

Chapelle, J.-P. (17 March 1984). Au-delà du cholestérol : les apo-lipoprotéines [Paper presentation]. Journée de Cardiologie, Liège, Belgium.

Hans, P., Born, J. D., Chapelle, J.-P., & Albert, A. (25 February 1984). Perspectives diagnostiques et pronostiques du dosage de la CK-MB dans le LCR ventriculaire en neurotraumatologie [Poster presentation]. Réunion de la Société Belge de Soins Intensifs, Louvain, Belgium.

Hans, P., Born, J. D., Chapelle, J.-P., Spyropoulos, E., & Bodson, L. (1984). Changes in cerebrospinal fluid enzyme activity after severe head injury. Diagnostic and prognostic values. Acta Anaesthesiologica Belgica, 35 (1), 79-86.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (1984). How should we proceed when a myocardial infarction is suspected. Acta Clinica Belgica, 39 (6), 393-5. doi:10.1080/22953337.1984.11719039
Peer Reviewed verified by ORBi

Chapelle, J.-P. (1984). Serum creatine kinase MM sub-band determination by isoelectric focusing: a potential method for the monitoring of myocardial infarction. Clinica Chimica Acta, 137 (3), 273-81. doi:10.1016/0009-8981(84)90115-3
Peer Reviewed verified by ORBi

Albert, A., Chapelle, J.-P., Heusghem, C., & Harris, E. K. (1984). Efficient biochemical monitoring and survival assessment after an acute myocardial infarction [Poster presentation]. 36th National Meeting of the American Association for Clinical Chemistry, Washington, United States.

Chapelle, J.-P., & Heusghem, C. (1984). Serum CK-MM0 isoenzyme : a new approach to the biochemical monitoring of a myocardial infarct. European Heart Journal, 5 (Abstr Suppl.1), 187.
Peer Reviewed verified by ORBi

El Allaf, D., Marchal, C., El Allaf, M., Chapelle, J.-P., Deleixhe, A., & Carlier, J. (1984). Evolution, en fonction de l'age et du sexe, de l'uree, de la creatinine et de la clairance de la creatinine. Archives Internationales de Physiologie et de Biochimie, 92 (3), 249-54. doi:10.3109/13813458409104506
Peer Reviewed verified by ORBi

Born, J. D., Hans, P., Chapelle, J.-P., & Bonnal, J. (1984). Correlation entre l'echelle de Liege et un marqueur biochimique de la lesion cerebrale. Neuro-Chirurgie, 30 (5), 319-23.
Peer Reviewed verified by ORBi

Albert, A., Chapelle, J.-P., Heusghem, C., & Harris, E. K. (1984). Efficient biochemical monitoring and survival assessment after an acute myocardial infarction. Clinical Chemistry, 5 (abstr suppl.1), 187.
Peer Reviewed verified by ORBi

Albert, A., Harris, E. K., CHAPELLE, J.-P., Heusghem, C., & Kulbertus, H. (January 1984). On the interpretation of serial laboratory measurements in acute myocardial infarction. Clinical Chemistry, 30 (1), 69-76. doi:10.1093/clinchem/30.1.69
Peer Reviewed verified by ORBi

Albert, A., Chapelle, J.-P., Heusghem, C., & Kulbertus, H. (September 1983). Continuous risk assessment using serial data in patients with myocardial infarction [Poster presentation]. 3rd Joint Meeting of the Working Groups of the European Society of Cardiology, Spa, Belgium.

Chapelle, J.-P. (29 July 1983). Dynamic outcome prediction from repeated laboratory measurements made on intensive care unit patients. Application to acute myocardial infaction [Paper presentation]. IV International Meeting on clinical Laboratory Organization and Management, Uppsala, Sweden.

Chapelle, J.-P., Albert, A., & Heusghem, C. (July 1983). Are total lactate deshydrogenase measurements superior to LD isoenzyme determinations as risk predictors in acute myocardial infarction? [Poster presentation]. 5th European Congress of Clinical Chemistry, Budapest, Hungary.

El Allaf, M., Chapelle, J.-P., El Allaf, D., Van Cauwenberge, H., & Heusghem, C. (May 1983). Multiple myeloma assessment by isoelectric focusing in patients with apparently increased beta-globulin on cellulose acetate electrophoresis [Poster presentation]. XXXIst Colloquium - Protides of the Biological Fluids, Brussels, Belgium.

Chapelle, J.-P., Albert, A., Smeets, J. P., Maréchal, J. P., Heusghem, C., & Kulbertus, H. E. (May 1983). Does lactate dehydrogenase isoenzyme-5 contribute to the predictive power of total lactate dehydrogenase in myocardial infarction? Clinical Chemistry, 29 (5), 774-7. doi:10.1093/clinchem/29.5.774
Peer Reviewed verified by ORBi

Hans, P., Born, J. D., Chapelle, J.-P., & Milbouw, G. (1983). Creatine kinase isoenzymes in severe head injury. Journal of Neurosurgery, 58 (5), 689-92. doi:10.3171/jns.1983.58.5.0689
Peer Reviewed verified by ORBi

Albert, A., Chapelle, J.-P., Heusghem, C., & Kulbertus, H. (1983). Continuous risk assessment using serial data in patients with myocardial infarction. European Heart Journal Supplements: Journal of the European Society of Cardiology, 4 (Suppl. E), 61.
Peer Reviewed verified by ORBi

Chapelle, J.-P., & Heusghem, C. (January 1983). Biomedical risk analysis in myocardial infarction [Paper presentation]. 16th Annual Conference in System Sciences, Honolulu, United States - Hawaii.

Albert, A., Chapelle, J.-P., Heusghem, C., & Harris, E. K. (1983). Improved use of serial laboratory data in acute myocardial infarction. Clinical Chemistry, 28, 1573.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Albert, A., Delens, G., Ney, J.-M., Vitek, P. J., & Heusghem, C. (1983). Le système de gestion de laboratoire BALAS : le module "microbiologie" [Paper presentation]. 2ème Panorama de l'Informatique, Liège, Belgium.

Delwaide, P., Chapelle, J.-P., & Albert, A. (03 December 1982). Interprétation des données en chimie clinique. Méthodes classiques et innovatrices [Paper presentation]. Colloque interdisciplinaire de l'ALLg, Sart Tilman, Liège, Belgium.

Chapelle, J.-P., Albert, A., & Heusghem, C. (October 1982). Un index évolutif pour la surveillance, en cours d'hositalisation, des patients atteints d'infarctus du myocarde [Poster presentation]. 5ème Colloque International de Biologie prospective, Pont-à-Mousson, France.

Smeets, J. P., Foidart, G., Dubois, C., Albert, A., Chapelle, J.-P., Henrard, L., & Kulbertus, H. (September 1982). First year prognosis after myocardial infarction assassed from simple clinical findings [Poster presentation]. The first year after a myocardial infarction, Sart Tilman, Belgium.

Chapelle, J.-P., Albert, A., Kulbertus, H., & Heusghem, C. (September 1982). Th long-term prognostic significance of biochemical measurements obtained during the acute phase of myocardial infarction [Paper presentation]. First year after a myocardial infarction, Sart Tilman, Liège, Belgium.

Albert, A., Chapelle, J.-P., Heusghem, C., & Harris, E. K. (August 1982). Improved use of serial laboratory data in acute myocardial infarction [Poster presentation]. XXth Congress of the American Association for Clinical Chemistry, Anaheim, United States.

Chapelle, J.-P., Albert, A., Smeets, J. P., Heusghem, C., & Kulbertus, H. (August 1982). Hyperuricemia: a risk factor for acute myocardial infarction in women? [Poster presentation]. XVIth International Congress of Internal Medicine, Prague, CSK.

Chapelle, J.-P., Albert, A., Kulbertus, H., & Heusghem, C. (August 1982). Continuous assessment of risk using a dynamic prognostic index in patients with myocardial infarction [Poster presentation]. XVIth International Congress of Internal Medicine, Prague, CSK.

Chapelle, J.-P. (28 May 1982). Définition d'index de risque dans l'infarctus myocardique.

Chapelle, J.-P., Smeets, J. P., Albert, A., & Kulbertus, H. (April 1982). Comparison of automated and manual techniques for the determination of creatine kinase MB [Poster presentation]. International Congress on automation in the Clinical Laboratory, Barcelona, Spain.

Chapelle, J.-P. (25 February 1982). Biologie clinique de l'infarctus du myocarde. Données nouvelles [Paper presentation]. Réunion d'information scientifique des Biologistes cliniciens, Liège, Belgium.

Chapelle, J.-P., Albert, A., Smeets, J. P., Boland, J., Heusghem, C., & Kulbertus, H. (1982). Serum myoglobin determinations in the assessment of acute myocardial infarction. European Heart Journal, 3 (2), 122-129. doi:10.1093/oxfordjournals.eurheartj.a061273
Peer Reviewed verified by ORBi

Chapelle, J.-P., Albert, A., Boland, J., Smeets, J.-P., Heusghem, C., & Kulbertus, H. (1982). Critical evaluation of serum uric acid levels in acute myocardial infarction. Clinica Chimica Acta, 121 (2), 147-157. doi:10.1016/0009-8981(82)90053-5
Peer Reviewed verified by ORBi

Hans, P., Born, J. D., Chapelle, J.-P., & Milbouw, G. (1982). Etude isoenzymatique de la creatine kinase chez les traumatises craniens en coma. Neuro-Chirurgie, 28 (1), 9-12.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Albert, A., Smeets, J. P., Heusghem, C., & Kulbertus, H. (1982). Effect of the haptoglobin phenotype on the size of a myocardial infarct. New England Journal of Medicine, 307 (8), 457-63. doi:10.1056/NEJM198208193070801
Peer Reviewed verified by ORBi

Chapelle, J.-P., Albert, A., Heusghem, C., & Kulbertus, H. (September 1981). Evaluation of risk using serial laboratory data in acute myocardial infarction [Paper presentation]. III International Meeting on Clinical Laboratory Organization and Management, Graz, Austria.

Chapelle, J.-P., Albert, A., Smeets, J. P., Heusghem, C., & Kulbertus, H. (September 1981). Quantitative aspects of serum myoglobin changes in acute myocardial infarction [Poster presentation]. Second Joint Meeting of the Working Groups of the European Society of Cardiology, Pavia, Italy.

Chapelle, J.-P. (24 March 1981). Vers la stratifcation précoce du risque chez le patient atteint d'infarctus myocardique aigu.

Chapelle, J.-P., Albert, A., Smeets, J. P., Demoulin, J. C., Foidart, G., Boland, J., Heusghem, C., & Kulbertus, H. (1981). Early assessment of risk in patients with acute myocardial infarction. European Heart Journal, 2 (3), 187-96. doi:10.1093/oxfordjournals.eurheartj.a061193
Peer Reviewed verified by ORBi

Chapelle, J.-P., Albert, A., Smeets, J. P., Kulbertus, H., & Heusghem, C. (1981). Significance of serum myoglobin levels in the early assessment of myocardial infarction [Poster presentation]. XI International/IV European Congress of Clinical Chemistry, Vienna, Austria.

Chapelle, J.-P., Albert, A., Kulbertus, H., & Heusghem, C. (1981). Is the evolution of myocardial infarction haptoglobin phenotype-dependent? [Poster presentation]. XI International/IV European Congress of Clinical Chemistry, Vienna, Austria.

Chapelle, J.-P., Bertrand, A., & Heusghem, C. (1981). The protection of creatine kinase MM sub-bands by EDTA during storage. Clinica Chimica Acta, 115 (3), 255-62. doi:10.1016/0009-8981(81)90239-4
Peer Reviewed verified by ORBi

Heusghem, C., Albert, A., Chapelle, J.-P., Delens, G., Ney, J.-M., & Vitek, P. J. (1981). La gestion informatique du Laboratoire de Chimie Medicale de l'Universite de Liege. Revue Médicale de Liège, 36 (21), 798-802.
Peer reviewed

Chapelle, J.-P., Albert, A., Smeets, J. P., Heusghem, C., & Kulbertus, H. (1981). Quantitative aspect of serum myoglobin changes in acute myocardial infarction. European Heart Journal, 2 (A), 213.
Peer Reviewed verified by ORBi

Chapelle, J.-P., Albert, A., Smeets, J. P., Heusghem, C., & Kulbertus, H. (1981). The prognostic significance of serum alpha 1-acid glycoprotein changes in acute myocardial infarction. Clinica Chimica Acta, 115 (2), 199-209. doi:10.1016/0009-8981(81)90076-0
Peer Reviewed verified by ORBi

Albert, A., Chapelle, J.-P., & Smeets, J. P. (1981). Stepwise probit discrimination with specific application to short-term prognosis in acute myocardial infarction. Computers and Biomedical Research, an International Journal, 14 (5), 391-8. doi:10.1016/0010-4809(81)90018-5
Peer Reviewed verified by ORBi

Chapelle, J.-P., Smeets, J. P., Sourdeau, L., Albert, A., Heusghem, C., & Kulbertus, H. (November 1980). Plasma alpha-1-acid glycoprotein and haptoglobin changes in acute myocardial infarction: relationship to early mortality [Poster presentation]. 1st Africain and Mediterranean Congress of Clinical Chemistry, Milan, Italy.

Chapelle, J.-P. (29 September 1980). Significance of plasma myoglobin levels in the assessment of acute myocardial infarction [Paper presentation]. Réunion de Cardiologie, Liège, Belgium.

Verdin, L., Albert, A., & Chapelle, J.-P. (September 1980). Intérêt du dosage de la myoglobine dans la stratification précoce du risque chez les patients atteints d'infarctus du myocarde aigu [Poster presentation]. Colloque "Diag 80", Bruxelles, Belgium.

Albert, A., Chapelle, J.-P., & Kulbertus, H. (June 1980). Early Risk Scale in Acute Myocardial Infarction [Poster presentation]. VIII European Congress of Cardiology, Paris, France.

Rigo, P., Betz-Rigo, C., Smeets, J. P., Demoulin, J. C., Chapelle, J.-P., & Kulbertus, H. (March 1980). Infarct size estimates from myocardial thallium and phosphate scans. prognostic implications [Poster presentation]. 29th Annual Scientific Session of the American College of Cardiology, Houston, United States.

Chapelle, J.-P., & Heusghem, C. (March 1980). Further heterogeneity demonstarted for serum creatine kinase isoenzyme MM. Clinical Chemistry, 26 (3), 457-62.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (04 February 1980). High predictive value of LDH in acute myocardial infarction [Paper presentation]. Meeting on Recent Advances in Myocardial Infarction, Liège, Belgium.

Chapelle, J.-P., Albert, A., Heusghem, C., Smeets, J. P., & Kulbertus, H. (1980). Predictive value of serum enzyme determinations in acute myocardial infarction. Clinica Chimica Acta, 106 (1), 29-38. doi:10.1016/0009-8981(80)90371-X
Peer Reviewed verified by ORBi

Brunain, J. P., Chapelle, J.-P., Albert, A., Demoulin, J. C., Limet, R., & Lamy, M. (06 October 1979). Monitoring enzymatique par courbes étalonnées de percentiles chez l'opéré cardiaque [Poster presentation]. Congrès belge d'Anesthésiologie, Anvers, Belgium.

Heusghem, C., Albert, A., Plomteux, G., Chapelle, J.-P., Toulet, J., Kulbertus, H., Demoulin, J. C., Foidart, G., & Smeets, J. P. (1979). Strategie nouvelle en matiere d'interpretation des donnees en biologie medicale. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 134 (11), 659-77.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (14 December 1978). Applications de la focalisation isoélectrique en chimie clinique [Paper presentation]. Réunion d'information scientifique des Biologistes cliniciens, Liège, Belgium.

Chapelle, J.-P., Albert, A., Brunain, J. P., Lamy, M., & Heusghem, C. (October 1978). Signification diagnostique et pronostique des modifications biochimiques enregistrées après chirurgie cardiaque coronarienne [Poster presentation]. 4ème Colloque International de Biologie Prospective, Pont-à-Mousson, France.

Chapelle, J.-P., Albert, A., Heusghem, C., Demoulin, J. C., Collignon, P., & Kulbertus, H. (25 June 1978). Biochemical approach to the Prognosis of acute myocardial infarction [Poster presentation]. First Joint Meeting of the Working Groups of the European Society of Cardiology, Brighton, United Kingdom.

Chapelle, J.-P. (27 April 1978). Infarctus du myocarde. Diagnostic précoce, évaluation quantitative des lésions [Paper presentation]. Réunion d'Information scientifique des Biologistes cliniciens, Liège, Belgium.

Chapelle, J.-P., Buret, J., & Heusghem, C. (23 March 1978). Intérêt des paramètres biochimiques dans le pronostic à court terme de l'infarctus du myocarde [Paper presentation]. Réunion de la Société française de Biologie clinique, Paris, France.

Chapelle, J.-P., Heusghem, C., & Buret, J. (23 March 1978). Interférence de l'adenylate kinase dans le dosage de la CK-MB dans la phase précoce de l'infarctus du myocarde [Paper presentation]. Réunion de la Société française de Biologie clinique, Paris, France.

Heusghem, C., Chapelle, J.-P., Albert, A., Demoulin, J. C., & Kulbertus, H. (1978). Multivariate analysis of biochemical data in acute myocardial infarction [Poster presentation]. X International Congress of Clinical Chemistry, Mexico, Mexico.

Chapelle, J.-P. (16 November 1977). Comparaison des méthodes de dosage des isoenzymes de la CK [Paper presentation]. Réunion de la Société Belge de Chimie Clinique, Liège, Belgium.

Chapelle, J.-P., Albert, A., Demoulin, J. C., Heusghem, C., & Kulbertus, H. (08 October 1977). Eléments de pronostic dans l'infarctus du myocarde au stade aigu [Paper presentation]. Colloque de la Société Belge de Médecine Interne, Liège, Sart Tilman, Belgium.

Chapelle, J.-P. (17 May 1977). Interférence de l'adenylate kinase dans le dosage de la creatine phosphokinase [Paper presentation]. Réunion de la Société Belge de Chimie Clinique, Gand, Belgium.

Cornélis, A., & Chapelle, J.-P. (1976). Apport de la resonance magnetique nucleaire du carbone 13 (RMN13C) a l'etude systematique des glucosides seco-iridoides: confirmation de structure du swertiamaroside. Pharmaceutica Acta Helvetiae, 51 (6), 177-80.
Peer Reviewed verified by ORBi

Chapelle, J.-P. (1976). Vogeloside et acide secologanique, glucosides secoiridoides d'Anthocleista vogelii. Planta Medica, 29 (3), 268-74. doi:10.1055/s-0028-1097661
Peer Reviewed verified by ORBi

Chapelle, J.-P. (1974). Constituants chimiques des feuilles d'Anthocleista vogelii. Planta Medica, 26 (4), 301-4. doi:10.1055/s-0028-1099391
Peer Reviewed verified by ORBi

Chapelle, J.-P. (1972). Variation saisonniere des valepotriates chez Valeriana procurrens Wallr. indigene. Journal de Pharmacie de Belgique, 27 (5), 570-6.
Peer Reviewed verified by ORBi

Contact ORBi